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                                                                  Summary 
Despite intense research efforts, the repair of large bone defects is still not satisfactory 
and remains a major challenge in Orthopaedic Surgery. In this context bone tissue engineering 
has emerged as a promising strategy. However, one of the fundamental principles underlying 
tissue engineering approaches is that newly formed tissue must maintain sufficient 
vascularization to support its growth. Thus an active blood vessel network is an essential 
pre-requisite for scaffold constructs to integrate within existing host tissue. Currently, great 
efforts are made to address this problem employing transplantation of vascular cells and 
loading of appropriate biological factors.  
Endothelial progenitor cells (EPCs) are a heterogeneous subpopulation of bone marrow 
mononuclear progenitor cells with potential for differentiation to the endothelial lineage and 
thus vasculogenic capacity. However, clinical studies reported that with the increase of age, 
increased susceptibility to apoptosis and accelerated senescence may contribute to the 
numerical and functional impairments observed in EPCs, which may lead to a reduced 
angiogenic capacity and an increased risk of vascular disease. Hence attention has 
increasingly been paid to enhance mobilization and differentiation of EPCs for therapeutic 
purposes.  
 A large body of evidence indicates that in Traditional Chinese Medicine (TCM) a 
plethora of herbs and herbal extracts are effective in the treatment of vascular diseases such as 
chronic wounds, diabetic retinopathy and rheumatoid arthritis. Thus, it seems rational to 
explore these medicinal plants as potential sources of novel angiomodulatory factors. 
In this thesis we demonstrated that treatment with TCM herbal extracts promote cell 
growth, cell migration, cell-matrix and capillary-like tube formation of BM-EPCs. Among 
these TCM extracts, Salidroside (SAL) and Icariin (ICAR) incubation increased VEGF and 
nitric oxide secretion, which in turn mediated the enhancement of angiogenic differentiation 
of BM-EPCs. A mechanic evaluation provided evidence that SAL stimulates the 
phosphorylation of Akt, mammalian target of rapamycin (mTOR) and ribosomal protein S6 
  
kinase (p70S6K), as well as phosphorylated ERK1/2, which is associated with the cell 
migration and tube formation. Furthermore, a pilot in vivo study showed that SAL has the 
potential to enhance bone formation in a murine femoral critical-size bone defects model.  
Another new finding of the present study is that hydrogen peroxide (H2O2)-induced 
cytotoxicity is counteracted by TCM extracts. We found that SAL, Salvianolic acid B (SalB) 
and ICAR significantly abrogated H2O2-induced cell apoptosis, reduced the intracellular level 
of reactive oxygen species (ROS) and nicotinamide adenine dinucleotide phosphate-oxidase 
(NADPH) expression, and restored the mitochondrial membrane potential of BM-EPCs. Our 
data suggest that this protective effect of SalB is mediated by the activation of mTOR, 
p70S6K, 4EBP1, and by the suppression of MKK3/6-p38 MAPK-ATF2 and ERK1/2 
signaling pathways after H2O2 stress. In addition, the investigation also demonstrates that 
ICAR owns the ability to inhibit apoptotic and autophagic programmed cell death via 
restoring the loss of mTOR and attenuation of ATF2 activity upon oxidative stress. 
Based on the outcomes of the present work, we propose SAL, SalB and ICAR as novel 
proanigiogenic and cytoprotective therapeutic agents with potential applications in the fields 
of systemic and site-specific tissue regeneration including ischaemic disease and extended 
musculoskeletal tissue defects. 
 
 
 
 
 
 
 
 
  
                                                           Zusammenfassung 
Trotz intensiver Forschung stellt die Behandlung von großen Knochendefekten die 
regenerative Medizin vor eine große Herausforderung. Zahlreiche Knochenersatzmaterialien 
sowie Methoden zur Regeneration von Knochengewebe durch Tissue Engineering haben sich 
in der Praxis als wirksame Strategie herausgebildet. Um größere Knochendefekte langfristig 
erfolgreich durch regenerierbare Implantate ersetzen zu können, muss neu gebildetes Gewebe 
jedoch ausreichend durch ein Gefäß-/ Kapillarnetz vaskularisiert werden, um eine 
ausreichende Versorgung des Gewebes zu gewährleisten. Daher wird die Entwicklung 
vaskularisierter Knochenimplantate als ein aussichtsreicher Ansatz für den Ersatz großer 
Knochendefekte angesehen. Die Transplantation von Gefäßzellen in Kombination mit 
Faktoren die die Knochenregeneration stimulieren, stellt ein vielversprechendes Konzept dar. 
Endotheliale Vorläuferzellen (EPCs) sind eine heterogene Subpopulation von 
mononukleären Vorläuferzellen aus dem Knochenmark mit dem Potenzial zur 
Differenzierung in die endotheliale Linie. Klinische Studien zeigten, dass mit der Zunahme 
des Alters, eine erhöhte Anfälligkeit für programmierten Zelltod (Apoptose) und eine 
beschleunigte Alterung im Zusammenhang mit in EPCs beobachteten numerischen und 
funktionalen Störungen steht. Dies führt zu einer verminderten angiogenen Kapazität und 
kann zu einem erhöhten Risiko von Gefäßkrankheit beitragen. Daher hat sich die verstärkte 
Aufmerksamkeit bezahlt gemacht, die Mobilisierung und Differenzierung von EPCs für 
therapeutische Zwecke zu verbessern. 
Eine große Anzahl von Studien hat gezeigt, dass sich in der traditionellen chinesischen 
Medizin (TCM) eine Vielzahl von Kräutern und Kräuterextrakten bei der Behandlung von 
vaskulären Erkrankungen, wie chronischen Wunden, diabetischer Retinopathie und 
rheumatoider Arthritis bewährt haben. Diese Heilpflanzen als potentielle Quellen für 
neuartige angiomodulatorische Faktoren zu erforschen, stellt ein innovatives Konzept dar. 
In dieser Arbeit wurde gezeigt, dass die Behandlung mit TCM das Zellwachstum, die 
Zellmigration, eine Zell-Matrix-und Kapillar-ähnlichen Gefäßverzweigungen von EPCs 
  
fördert. Eine Inkubation mit Salidrosid (SAL) und Icariin (ICAR) erhöhte die Vascular 
Endothelial Growth Factor (VEGF)- und Stickoxid-Sekretion, das wiederum eine Verstärkung 
der angiogenen Differenzierung von EPCs vermittelte. Mechanische Untersuchungen belegten, 
dass SAL die Phosphorylierung der Proteinkinase B (Akt), dem Zielgen von Rapamycin 
(mTOR) und der ribosomalen Protein S6 Kinase (p70S6K) sowie der mitogen-aktivierten 
Proteinkinasen ERK1/ 2 stimulierte. Darüber hinaus zeigten erste in-vivo-Experimente, dass 
SAL deutlich die Knochenbildung in kritischen Knochendefekten von immundefizienten 
Mäusen steigerte. 
Eine weitere neue Erkenntnis der vorliegenden Studie ist, dass Wasserstoffperoxid (H2O2) 
-induzierter Zytotoxizität durch TCM entgegengewirkt werden kann. SAL, Salvianolsäure B 
(SalB) und ICAR minimierten signifikant die H2O2 -induzierte Apoptose, reduzierten die 
Bildung intrazellulärer reaktiver Sauerstoffspezies (ROS) und die Expression von 
Nicotinamidadenindinucleotidphosphat-Oxidase (NADPH) in EPCs. Die Ergebnisse belegen, 
dass die protektive Wirkung von SalB durch die Aktivierung von mTOR, p70S6K, 4EBP1 
und durch die Unterdrückung der MKK3/6-p38 MAPK - ATF2 und ERK1/2 Signalwege nach 
H2O2 Stress vermittelt wird. Die Untersuchungen zeigten des Weiteren, dass ICAR die 
Fähigkeit besitzt apoptotisch und autophagisch induzierten programmierten Zelltod zu 
inhibieren, indem es den Verlust von mTOR ausgleicht und eine ATF2 Aktivität, induziert 
durch oxidativem Stress, minimiert. 
Basierend auf den Ergebnissen der vorliegenden Studie etablierten sich SAL, SalB und 
ICAR als neuartige proanigiogene und zellschützende therapeutische Mittel. Möglichen 
Anwendungen könnten sich in den Bereichen der systemischen und ortsspezifischen 
Geweberegeneration einschließlich ischämischer Erkrankungen und Muskel-Skelett 
ausgedehnten Gewebedefekten finden. 
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1. INTRODUCTION 
 
                1.1 Current concepts and future directions for repair of bone defect  
Bone regeneration is a complex, well-orchestrated biological process that comprised of 
a series of events of bone induction and conduction, involving a number of cell types, 
intracellular and extracellular molecular-signaling pathways, with a definable temporal and 
spatial sequence, in an effort to optimize skeletal repair and restore skeletal function (Cho et 
al., 2002; Einhorn, 1998). Multiple factors regulate this cascade of events by affecting 
different sites in the osteoblast and chondroblast lineage through various processes such as 
migration, proliferation, chemotaxis, differentiation, inhibition, and extracellular protein 
synthesis (Colnot et al., 2005).  
Bone possesses the intrinsic regeneration capacity as part of the repair process in 
response to injury, during skeletal development or continuous remodeling throughout adult 
life (Dimitriou et al., 2011). However, there are complex clinical conditions requires bone 
regeneration in large quantity, such as for skeletal reconstruction of large bone defects 
created by trauma, infection, tumor resection and congenital malformation, or cases in 
which the regenerative process is compromised, including avascular necrosis, atrophic 
non-unions and osteoporosis (Dimitriou et al., 2011; Jimi et al., 2012).  
At present, the gold standard for the reconstruction of large bone defects is the use of 
autogenous bone grafts. While autogenous bone graft is the most eﬀective clinical method, 
surgical stress to the part of the bone being extracted and the quantity of extractable bone 
limit this method. One alternative to autograft is allograft, whose surfaces support bone 
formation and allow structural restoration of the skeleton. However, allograft bone lacks 
viable osteoprogenitor cells and has low levels of growth factors.  
With the ongoing research in all related fields, treatment strategies should aim to 
address all prerequisites for optimal bone healing, including osteoconductive matrices, 
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osteoinductive factors, osteogenic cells and mechanical stability, following the ‘diamond 
concept’ suggested for fracture healing (Giannoudis et al., 2007).  
 
                                    1.2 The role of angiogenesis in bone healing 
Angiogenesis is the formation of new blood vessels occurring in an adult through 
migration and proliferation of endothelial cells (ECs), and tubular structures formation, 
which plays a role in many physiological processes (i.e. remodeling of ischemic muscle, 
wound healing, fracture repair) as well as in pathological process such as rheumathoid 
arthritis and metastases (Albrecht-Schgoer et al., 2012; Harris et al., 2013; Mobasheri, 2013). 
Intravital microscopy and angiographic analysis in bone chamber models indicate that 
angiogenesis temporally precedes osteogenesis, as predicted by Trueta’s early work (Trueta 
and Buhr, 1963). In bone, vasculature is essential for cartilage resorption and angiogenesis 
temporally precedes osteogenesis: the origin of bone is the artery carrying calcium and 
phosphate ions. Osteogenesis takes place near newly formed vessels that mediate delivery of 
osteoprogenitor cells, secrete mitogens for osteoblasts, and transport nutrients and oxygen. 
Inadequate or inappropriate bone vascularity is associated with decreased bone formation 
and bone mass. Risk factors for impaired bone healing include: poor blood supply, poor 
apposition of fractured bone ends, interposition of soft tissues or necrotic bone between 
bone fragments, inadequate immobilization, infection, drug use (e.g. corticosteroid therapy 
or nicotine), advanced age, and systemic disorders, such as diabetes or poor nutrition 
(Einhorn, 1995). Negative effects on the vascular system might be the mechanism whereby 
many other risk factors delay or impair bone healing (Glowacki, 1998). 
In the mature established vasculature, the endothelium plays a pivotal role in the 
maintenance of homeostasis of the surrounding tissue providing the communicative network 
to neighbouring tissues to respond to requirements as needed. Furthermore, the vasculature 
provides the necessary factors such as growth factors, hormones, cytokines, chemokines and 
metabolites needed by the surrounding tissue and acts, when needed, as a barrier to limit the 
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movement of molecules and cells. A fully functional vascular network within 
bone-engineered constructs is crucial and remains a major challenge in bone tissue 
engineering (Grellier et al., 2009). After a bone construct is implanted in vivo, induction of 
initial vascularization is important: in particular, the survival of osteogenic cells in the 
interior of the scaffold is often threatened by the limited extent of initial vascularization 
(Kneser et al., 1999; Kneser et al., 2006). The implanted construct requires ongoing 
vascularization to ensure survival and integration, since it takes weeks for the host’s blood 
circulation to establish sufficient supply to the implant (Jain, 2003; Kaigler et al., 2006; 
McCarthy, 2006). Several strategies have been proposed to address this problem. For 
example, the addition of vascular cells such as ECs might offer several advantages over 
seeding of osteogenic cells alone (Unger et al., 2007).  
However, as the bone development and remodeling depend on complex interactions 
between bone-forming osteoblasts and other cells present within the bone microenvironment, 
particularly ECs that may be pivotal members of a complex interactive network acted on 
bone, the mode of communication between the bone cells and vascular cells, at the 
molecular level, has yet to be fully elucidated. 
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Figure 1. A schematic diagram of endochondral bone formation. (A) Mesenchymal cells condense and 
(B) differentiate into chondrocytes forming an avascular cartilage model of the future bone. (C) At the 
centre of condensation the chondrocytes cease proliferating and become hypertrophic. (D) Perichondral 
cells adjacent to the hypertrophic chondrocytes differentiate into osteoblasts forming a bone collar. The 
hypertrophic cartilage regulates the formation of mineralised matrix; the release of angiogenic factors to 
attract blood vessels and undergoes apoptosis. (E) The coordination of osteoblasts and vascular invasion 
form the primary spongiosa. The chondrocytes continue to proliferate with concomitant vascularization 
resulting in a coordinated process that lengthens the bone. Osteoblasts of the bone collar will eventually 
form cortical bone; while osteoblasts precursors located in the primary spongiosa will eventually form 
trabecular bone. (F) At the ends of the bone, secondary ossification centres develop through cycles of 
chondrocyte hypertrophy, vascular invasion and osteoblast activity. Columns of proliferating 
chondrocytes form in the growth plate beneath the secondary ossification centre. Finally, expansion of 
stromal cells and hematopoietic marrow starts to take place in the marrow space (Adapted from 
Kronenberg, 2003 and Horton, 1990). 
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                             1.3 Bone regeneration induced by angiogenic factors 
With improved understanding of fracture healing and bone regeneration at the 
molecular level, a number of key molecules that regulate this complex physiological process 
have been identified, and are already in clinical use or under investigation to enhance bone 
repair. 
1.3.1 Vascular endothelial growth factor 
Previous studies have shown that endogenous VEGF is important for endochondral 
bone formation (Gerber et al., 1999; Haigh et al., 2000; Zelzer et al., 2002). VEGF is 
expressed before blood vessels are detected in developing mouse bones, and this expression 
is tightly associated with cells involved in bone formation (osteoblasts) (Zelzer et al., 2002). 
Inhibition of VEGF leads to expansion of the hypertrophic zone, loss of metaphyseal blood 
vessels and impaired trabecular bone formation in developing mice (Gerber et al., 1999; 
Haigh et al., 2000) and monkeys (Ryan, 1999). Thus, during development, VEGF is 
essential for blood vessel invasion of hyaline cartilage, growth late morphogenesis, and 
cartilage remodeling.  
It has been shown that both osteoblasts and hypertrophic chondrocytes express high 
levels of VEGF, thereby promoting the invasion of blood vessels and transforming the 
avascular cartilaginous matrix into a vascularized osseous tissue (Keramaris et al., 2008). 
VEGF promotes both vasculogenesis, i.e. aggregation and proliferation of mesenchymal 
stem cells (MSCs) into a vascular plexus, and angiogenesis, i.e. growth of new vessels from 
already existing ones (Kanczler and Oreffo, 2008; Street et al., 2002). Hence, VEGF plays a 
crucial role in the neoangiogenesis and revascularization at the fracture site. 
Given the importance of VEGF in normal bone repair, treatment with exogenous 
VEGF might be expected to promote angiogenesis and bone formation after injury- a 
hypothesis that is supported by several studies. Local administration of exogenous VEGF, in 
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the absence of a scaffold or progenitor cells, enhances bone formation in mouse femur 
fractures and rabbit radial critical-sized defects (Street et al., 2002).  
 
1.3.2 The transforming growth factor superfamily 
This superfamily includes most factors known to induce cartilage and bone formation 
during development, including TGF-βs, BMPs, growth and differentiation factors (GDFs) 
and activins. By virtue of shared receptors and structural homology, many of the members 
of this large family have overlapping activities, including stimulation of mesenchymal stem 
cell differentiation into chondrocytes or osteoblasts. However, their distinct expression 
pattern during bone repair, the developmental phenotypes observed when the genes are 
mutated or deleted and their activities when added exogenously in animal models or humans 
suggest subtly distinct roles in the process of bone repair. 
Transforming growth factor-β 
TGF-β, the prototypical member of this superfamily, is one of the most abundant 
cytokines present in bone matrix and exerts a dual role on osteoblastic bone formation. 
TGF-β stimulates early osteoblast differentiation by promoting recruitment and proliferation 
of osteoblast precursors and the expression of matrix proteins; on the other hand, it inhibits 
late osteoblast differentiation and mineralization (Alliston et al., 2001; Janssens et al., 2005; 
Maeda et al., 2004; Tang et al., 2009). TGF-β is a potent chemotactic stimulator of 
mesenchymal stem cells (MSCs) and it enhances proliferation of MSCs, preosteoblasts, 
chondrocytes and osteoblasts (Lieberman et al., 2002). It also induces the production of 
extracellular proteins such as collagen, proteoglycans, osteopontin, osteonectin, and alkaline 
phosphatase (Sandberg et al., 1993). Its main role is thought to be during mchondrogenesis 
and endochondral bone formation (Barnes et al., 1999). TGF-β may also initiate signaling 
for BMP synthesis by the osteoprogenitor cells, while it may inhibit osteoclastic activation 
and promote osteoclasts apoptosis (Mundy, 1996). 
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Bone morphogenetic proteins 
Several BMPs have been found to induce ectopic bone, due, at least partly, to 
stimulation of mesenchymal and osteoprogenitor cell proliferation and differentiation 
(Barnes et al., 1999; Reddi, 2001). Early pre-clinical studies indicated that BMP-2 
stimulates bone formation in critical size defects, fractures and spinal fusions (Egermann et 
al., 2006). In a rabbit ulna model, BMP-2 in a collagen sponge accelerates repair (Bouxsein 
et al., 2001) and overcomes the inhibitory effects of chronic glucocorticoid therapy on bone 
repair (Luppen et al., 2002). In rabbit tibial fractures, BMP-2 accelerates repair only in 
non-stable fractures, not in stable fractures (Bax et al., 1999). Injection of BMP-2 locally 
over the surface of calvariae of mice induces periosteal bone formation without a prior 
cartilage phase (Chen et al., 1997).  
 
1.3.3 Fibroblast growth factor 
Fibroblast Growth Factors (FGFs) belong to a family of polypeptides that regulate 
several important cellular processes. FGFs bind to high affinity FGF receptors (FGFR), 
leading to FGFR dimerization, phosphorylation  of  intrinsic  tyrosine residues  and  
activation  of  several  signal transduction  pathways (Beenken and Mohammadi, 2009).  
In the skeleton, FGF/FGFR signaling is an important regulator of prenatal and postnatal 
skeletal development. Cellular and genetic studies in mice and humans have revealed that 
FGFs control chondrogenesis and osteoblastogenesis by modulating the recruitment and 
activity of chondroblasts and cells of the osteoblast lineage (Dailey et al., 2005; Marie, 2003; 
Ornitz, 2005). During bone healing, FGFs are synthesized by monocytes, macrophages, 
mesenchymal cells, osteoblasts and chondrocyte. FGFs are identified during the early stages 
of fracture healing and they play a critical role in angiogenesis and MSC mitogenesis. 
α-FGF mainly effects chondrocyte proliferation and is probably important for chondrocyte 
maturation, whilst ß-FGF is expressed by osteoblasts and is generally more potent than 
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α-FGF (Lieberman et al., 2002). In a canine tibial osteotomy model, a single injection of 
FGF-2 was associated with an early increase in callus size (Nakamura et al., 1998). 
 
                           1.4 Angiogenic potential of endothelial progenitor cells 
In the early embryo, mesodermal stem cells in the bone marrow (BM) differentiate to 
form haemangioblasts, the common precursor of haematopoietic stem cells and 
endothelial-lineage angioblasts (Adams and Alitalo, 2007; Sirker et al., 2009). During 
vasculogenesis these immature but lineage-committed angioblasts, termed endothelial 
progenitor cells (EPCs), migrate and congregate into clusters, called blood islands, forming 
the primary vascular plexus from which a complex microcirculation arises (Paleolog, 2005; 
Risau, 1997). In contrast, adult vascular growth occurs primarily through angiogenesis 
whereby new capillaries develop endogenously from fully-differentiated endothelial cells 
(ECs) within existing vessels. Circulating EPCs share phenotypic characteristics with 
embryonic EPC (Hristov and Weber, 2004) and incorporate into sites of neovascularisation, 
suggesting a role for EPCs in angiogenic renewal (Iwami et al., 2004; Zhang et al., 2006a). 
In vitro, EPCs differentiated into endothelial lineage cells, and in animal models of ischemia, 
heterologous, homologous, and autologous EPCs were shown to incorporate into sites of 
active neovascularization. This finding was followed by diverse identifications of EPCs by 
several groups (Gunsilius et al., 2001; Lin et al., 2000; Peichev et al., 2000) using equivalent 
or different methodologies. Recently, similar studies with EPCs isolated from human cord 
blood have demonstrated their analogous differentiation into ECs in vitro and in vivo 
(Murohara et al., 2000; Nieda et al., 1997). These findings, together with other recent 
studies, are consistent with the notion of postnatal “vasculogenesis”, which is de novo 
vessel formation by in situ incorporation, differentiation, migration, and/or proliferation of 
BM-derived EPCs.  
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EPCs express endothelial-specific markers, including VEGF, vascular endothelial 
growth factor receptor 2 (VEGFR2), PECAM-1 (CD31), CD133, VE-cadherin, E-selectin 
and von Willebrand factor (vWF), which have various roles in cell-cell adhesion, vascular 
permeability and the modulation of other cellular responses during angiogenesis (Asahara et 
al., 1997; Michaud et al., 2006). Indeed, EPCs are implicated in angiogenesis stimulated by 
conditions such as coronary artery disease and myocardial infarction, confirmed by clinical 
observations of EPC mobilisation in such patients and incorporation into foci of 
pathological neovascularisation (Ding et al., 2007; Kawamoto and Asahara, 2007).  
Several studies have demonstrated that bone marrow-derived EPCs (BM-EPCs) 
functionally contribute to vasculogenesis during wound healing (Gill et al., 2001), limb 
ischemia (Iwaguro et al., 2002; Kalka et al., 2000), postmyocardial infarction (Edelberg et 
al., 2002; Shintani et al., 2001), endothelialization of vascular grafts (Bhattacharya et al., 
2000; Gill et al., 2001; Shi et al., 1998), or physiological cyclic organogenesis of 
endometrium (Asahara et al., 1999) under the influence of appropriate cytokines, growth 
factors and/or hormones through the autocrine, paracrine, and/or endocrine systems. 
Chemical stimuli may, at least in part, drive the response of EPCs during angiogenesis. 
These stimuli can be released from surrounding tissues, i.e. from within the 
microenvironment, or from the endothelial cells themselves. Indeed, it has been shown in 
hypoxic wounds of diabetic patients that EPCs in the BM respond by following chemokine 
gradients, resulting in their homing to sites of hypoxia where they can participate in 
neovascularisation (Gallagher et al., 2007). Consequently, the microenvironment in which 
progenitor cells are cultured is critical to their ability to maintain their progenitor status, i.e. 
to self-renew and give rise to differentiated cell types as and when recruited to do so.  
Nevertheless, current approaches to angiogenic therapies are problematic. Endogenous 
approaches most likely rely on the recruitment of circulating EPCs, and the delivery of a 
single pro-angiogenic substance is insufficient to elicit the complete and prolonged response 
necessary for effective angiogenesis (Milkiewicz et al., 2006; Williams et al., 2006). 
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Exogenous therapies involve administration of allogeneic donor EPCs, which with poor 
HLA matching leads to increased immune rejection resulting in reduced transplantation 
efficiency (Garmy-Susini and Varner, 2005; Shantsila et al., 2007). Furthermore, clinical 
studies reported that with the increase of age, increased susceptibility to apoptosis and 
accelerated senescence may contribute to the numerical and functional impairments 
observed in EPCs (Hoetzer et al., 2007; Kushner et al., 2009), which ultimately lead to the 
increased risk of vascular diseases and the prolonged and often complicated recovery from 
acute vascular events (Dimmeler and Zeiher, 2004; Scheubel et al., 2003). What’s more, the 
reduced levels of EPCs and functional impairment of endothelium are often indicated in 
patients with diabetes and cardiovascular disease (De Vriese et al., 2000; Vasa et al., 2001). 
Therefore, attention has increasingly been paid to enhance mobilization and differentiation 
of EPCs. 
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Figure 2. Kinetics of endothelial progenitor cells for neovascularization. Endothelial progenitor 
cells (EPCs) circulate in adult human peripheral blood and are mobilized from bone marrow by 
cytokines, growth factors, and ischemic conditions. Vascular injury is repaired by both angiogenesis 
and vasculogenesis mechanisms. Circulating EPCs contribute to repair of injured blood vessels 
mainly via a vasculogenesis mechanism. (Adapted from Murasawa, 2005). 
 
                                       1.5 Interaction of endothelium and bone 
In the context of the intricate relationship between angiogenesis and osteogenesis, 
communication between MSC and EC is one of the most important cellular interactions that 
orchestrates bone formation (Brandi and Collin-Osdoby, 2006; Carano and Filvaroff, 2003). 
Several mechanisms are involved: interaction between membrane molecules of two adjacent 
cells (adherens and tight junctions); gap junction communications which form direct 
cytoplasmic connections; and secretion of diffusible factors from cells, or from the 
extracellular matrix (Grellier et al., 2009). It has been demonstrated that ECs co-cultured 
with MSCs are able to establish microcapillary-like structures in a three dimensional 
spheroids (Rouwkema et al., 2006). Previous studies indicated that ECs could effect certain 
levels of osteogenesis, releasing bone morphogenetic proteins (Kaigler et al., 2005) and 
controlling the transcription factor Osterix for bone cell differentiation (Klinkner et al., 
2006).  
The intercellular signaling pathways of ECs have also been implicated in the functions 
of the osteoclastic lineage. For the recruitment of osteoclasts to areas of bone resorption, 
osteoclast precursors need to adhere and migrate through the endothelium in a tightly 
regulated mechanism similar to that of the systematic process of transendothelial migration 
of leukocytes and monocytes (Imhof and Dunon, 1997). It has been hypothesized that the 
endothelium may direct osteoclast precursor to specific areas of bone to help tightly control 
the resorptive process (Parfitt, 2000). Therefore, alterations in the micro-vascular supply 
network will ultimately affect the tightly regulated resorption sequence resulting in 
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decreases in bone formation, regeneration and repair as well as altered osteointegration of 
orthopaedic and dental implants (Burkhardt et al., 1987; Glowacki, 1998). 
 Bone ECs display their own distinctive characteristics, with a capacity to respond to 
bone regulators such as cytokines, estrogen and PTH (Streeten and Brandi, 1990; Streeten et 
al., 1989). In addition, bone endothelial cells secrete high levels of hormone B-type 
Natriuretic peptide (Bordenave et al., 2002) and express stromal cell-derived factor-1 
(SDF-1) (Imai et al., 1999).  
VEGF lead to an upregulation of BMP-2 in microvascular endothelial cells (Bouletreau 
et al., 2002) demonstrating the intricate signaling pathways affecting the interactive 
relationship of endothelial cells and cells of the osteoblastic lineage. The in vivo 
overexpression of HIF-1α showed striking and progressive increases in bone volume, and 
the amount of bone in the axial skeleton was directly proportional to the amount of skeletal 
vasculature (Wang et al., 2007). This study has established that the upregulation of HIF-1α 
and VEGF in osteoblasts specifically promoted bone formation secondarily to angiogenesis, 
clarifying the importance of osteoblast-derived VEGF in the coupling of angiogenesis to 
osteogenesis. Moreover, hypoxia lead to an upregulation of BMP-2 in microvascular 
endothelial cells (Bouletreau et al., 2002) demonstrating the intricate signaling pathways 
affecting the interactive relationship of endothelial cells and cells of the osteoblastic lineage.  
 
                                    1.6 Endothelial death due to oxidative stress 
The endothelium is located between the blood stream and the vessel wall which is the 
largest organ in the body. The endothelium regulates vascular homoeostasis through local 
elaboration of mediators that modulate vascular tonus and growth, as well as platelet 
adhesion, inflammation, fibrinolysis (Vane et al., 1990). The endothelium regulates vascular 
homoeostasis through local elaboration of mediators that modulate vascular tonus and 
growth, as well as platelet adhesion, inflammation, fibrinolysis (Vane et al., 1990). Vascular 
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endothelial cells normally perform several key homeostatic functions such as keeping blood 
fluid, regulating blood flow thereby modulating tissue macromolecule and fluid exchange. 
Endothelial dysfunction was first characterized in humans in 1986 by Ludmer et al, who 
demonstrated that atherosclerotic coronary arteries contracted in response to intracoronary 
infusion of acetylcholine, while normal coronaries showed dilatation (Ludmer et al., 1986). 
Endothelial dysfunction is frequently present in common chronic degenerative disorders, 
such as diabetes, hypertension and coronary artery disease (Brunner et al., 2005). The initial 
state of endothelial dysfunction is also considered as an early stage of atherosclerosis, 
finally leading to clinical manifestations like coronary artery disease. Multiple risk factors 
can cause endothelial injury or death including oxidative (Yamada et al., 2010), 
endoplasmic reticulum (Kim et al., 2007; Matsushita et al., 2011), and genotoxic stress 
(Basuroy et al., 2013), as well as activated pathways of injury mediated by the innate and 
adaptive immune systems.  
Interestingly, vascular endothelium is specifically sensitive to oxidative stress, and this 
is one of the mechanisms that causes endothelial dysfunction in frequent cardiovascular 
diseases and disorders, including atherosclerosis and acute coronary syndromes (Anderson 
et al., 1995; Libby, 2001). Notably, both the endothelium and the outer adventitial layer 
themselves initiate potent oxidative stress reactions in case of injury (Sorescu et al., 
2002).The mechanisms by which oxidative stress mediates alterations in vascular cell 
function are complex. Oxidative stress increases vascular endothelial permeability and 
promotes inflammatory response - a condition that is coupled with alterations in endothelial 
signal transduction and redox-regulated transcription factors (Beswick et al., 2001; Lee et al., 
2004; Orr et al., 2007). In addition, there is growing pathophysiological evidence that 
overproduction and accumulation of reactive oxygen species (ROS) leads to cell injury 
mediated by specific cellular macromolecules (lipids, proteins, and nucleic acids) that 
activate proatherogenic mechanisms (Fleury et al., 2002; Venkatesh et al., 2009). Oxidative 
stress-induced apoptosis is suggested to be dependent on mitochondrial dysfunction 
including mitochondrial derived-ROS. Thus, antioxidant therapy can be effective in 
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preventing oxidative stress-induced cell injury. However, the limited success of currently 
available antioxidant therapeutic agents (e.g. metalloporphyrins and catalytic antioxidants) 
expedites the development of innovative drugs.  
 
 
Figure 3. Molecular sources of vascular oxidative stress and pharmacologic intervention strategies. 
Vascular enzymes such as NADPH oxidase 2 (1), xanthine oxidase (2), and uncoupled endothelial nitric 
oxide synthase (3) can promote the production of reactive oxygen species (ROS) considerably. 
Eventually, these processes contribute to the development of endothelial dysfunction and vascular 
damage. Established and novel cardiovascular drugs, as well as dietary flavonoids, can attenuate cellular 
ROS concentrations via direct or indirect mechanisms. ACE: angiotensin-converting enzyme; Ang: 
angiotensin; AT1: Ang II type 1; CaM: calmodulin; ET-1: endothelin 1; FAD: flavindenine dinucleotide; 
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FMN: flavinmononucleotide; L-Arg: L-arginine; L-Cit: L-citrulline; PDGF: platelet -derived growth 
factor; TGF-β: transforming growth factor-β. (Adapted from Weseler, 2010) 
 
                                            1.7 ROS, antioxidant and signaling 
Reactive oxygen species (ROS), a heterogeneous population of biologically active 
intermediates, are generated as by-products of the aerobic metabolism and exhibit a dual 
role in biology. When produced in controlled conditions and in small amount, ROS may 
function as signaling intermediates, contributing to critical cellular functions such as 
proliferation, differentiation, and cell growth. However, ROS overproduction and, 
particularly, the formation of specific reactive species, inflicts cell death and tissue damage 
by targeting vital cellular components such as DNA, lipids, and proteins, thus arising as key 
players in disease pathogenesis.  
The most potent pathway for generating ROS is catalyzed by the phagocyte oxidase 
(Phox) complex, which is expressed by neutrophils and macrophages. In addition to Phox, 
ECs also express homologous nonphagocyte NADPD-dependent oxidase (Nox) complexes. 
Rather than contribute to EC barrier function and vascular remodeling (Rhee et al., 2000), 
endogenous Nox enzymes have also been considered to cause EC dysfunction in the 
pathogenesis of hypertension, atherosclerosis, cardiac hypertrophy, and heart failure 
(Keaney, 2005). Increasing evidence supports the idea that ROS generated from 
mitochondria significantly contribute to EC dysfunction and the progression of 
atherosclerosis (Nishikawa et al., 2000).  
The maintenance of intracellular redox homeostasis is dependent on a complex web of 
antioxidant molecules. These antioxidants include low molecular weight molecules such as 
glutathione, present in millimolar concentrations within cells, as well as an array of protein 
antioxidants that each has specific subcellular localizations and chemical reactivities. One 
important and emerging theme is that antioxidant proteins are not merely passive disposers 
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of intracellular oxidants but rather active participants in redox signaling. One of the earliest 
descriptions of this trend emerged from the interaction between thioredoxin (Trx) and the 
apoptosis signal-regulating kinase (ASK-1) (Saitoh et al., 1998). It had been previously 
known that agents such as TNF that activate ASK1 also stimulate ROS production. The link 
between ROS production and the subsequent activation of ASK1-dependent signaling 
appears to involve a redox-dependent interaction between ASK1 and Trx (Yamamoto et al., 
2003). 
Vascular cell dysfunction can be caused by dysbalance between mitogen activated 
protein kinase (MAPK) signaling and the redox state of vascular ECs. Different members of 
the MAPK family, such as extracellular signal-regulated kinases (ERKs), c-Jun N-terminal 
kinases (JNKs), and p38 mitogen-activated protein kinases (p38 MAPK) play important 
roles in the coordination of ROS-induced cellular stress responses (Matsuzawa and Ichijo, 
2008). Both duration and magnitude of toxicant exposure is suggested to be proportional to 
the state of MAPK activation thereby being determinative for the cell’s fate (Dickinson et 
al., 2002). As ROS are generated mainly as byproducts of mitochondrial respiration, 
mitochondria are thought to be the primary target of oxidative damage. Increasing evidence 
indicates that mitochondrial damage and dysfunction contribute to the pathological 
processes underlying the vascular disease (Ballinger et al., 2002; Knight-Lozano et al., 2002; 
Mercer et al., 2010). Mitochondrial dysfunction may lead to the activation of a series of 
caspases, and the subsequent events of apoptosis, e.g. the cleavage of poly (ADP-ribose) 
polymerase (PARP), a downstream substrate of activated caspases, protects DNA from 
oxidative damage. Dysregulation of any of these phenotypes in human ECs alters cell 
function thereby predisposing to vascular pathology. 
ROS are also known to affect proteins, such as NF-κB, Akt, ERK, CREB, and the 
EGF-receptor, in a manner which is thought to have a positive role in cell survival or 
proliferation (Bowie and O'Neill, 2000; Fantz et al., 2001; Huang et al., 2001; Salsman et al., 
2001; Suzaki et al., 2002). If damage to DNA or other cellular constituents is too great to 
repair, organisms have evolved mechanisms to promote apoptosis.  
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                                                 1.8 ROS regulate autophagy 
Autophagy is a self-digesting mechanism responsible for removal of long-lived 
proteins, damaged organelles, and malformed proteins during biosynthesis by lysosome 
(Baehrecke, 2005; Kondo et al., 2005). A body of evidence demonstrates that autophagic 
process is meant for regulating diverse cellular functions including growth, differentiation, 
response to nutrient deficit and oxidative stress, cell death, and macromolecule and 
organelle turnover (Klionsky et al., 2005; Massey et al., 2004).  
Autophagy begins with an isolation membrane, also known as a phagophore that is 
likely derived from lipid bilayer contributed by the endoplasmic reticulum (ER) and/or the 
trans-Golgi and endosomes (Axe et al., 2008; Simonsen and Tooze, 2009), although the 
exact origin of the phagophore in mammalian cells is controversial. This phagophore 
expands to engulf intracellular cargo, such as protein aggregates, organelles and ribosomes, 
thereby sequestering the cargo in a double-membraned autophagosome (Mizushima, 2007). 
The loaded autophagosome matures through fusion with the lysosome, promoting the 
degradation of autophagosomal contents by lysosomal acid proteases. Lysosomal permeases 
and transporters export amino acids and other by-products of degradation back out to the 
cytoplasm, where they can be re-used for building macromolecules and for metabolism 
(Mizushima, 2007). 
Conserved from yeast to humans, autophagy occurs at low basal levels to maintain 
cellular homeostasis through cytoplasmic and organelle turnover. For example, an animal 
model of Atg5-deﬁcient mice, although nearly normal at birth, they cannot survive the early 
neonatal starvation period: they have reduced circulating amino acids and decreased cardiac 
ATP (Hamacher-Brady et al., 2006). Under most circumstances, autophagy mechanism 
constitutes a stress adaptation pathway that protects cell survival. An apparent paradox is 
that autophagy is also considered a form of nonapoptotic programmed cell death called 
“programmed cell death type two” (PCD II) or “autophagic” cell death, which is 
characterized by morphologic and molecular features that are distinct from apoptosis (PCD I) 
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(Maiuri et al., 2007). This type of cell death has been defined by morphological criteria, but 
it is now clear that the mere presence of autophagosomes in dying cells is not sufficient to 
distinguish “cell death with autophagy” from “cell death by autophagy”.  
Certain cellular stresses can induce autophagy formation, such as oxidative stress. ROS 
are essential for autophagosome formation under starvation conditions through targeting 
cysteine protease HsAtg 4, an autophagy-related gene, leading to cell survival. However, 
little is known about the role of ROS in autophagy-induced cell death.  
High levels of ROS induce cell death, which often involves apoptosis through caspase 
activation (Pelicano et al., 2004). The NF-kB transcription factor could repress 
ROS-mediated autophagy. One study showed that tumor necrosis factor a-induced 
autophagy through ROS production in the absence of NF-kB activation but with NF-kB 
activation autophagy is repressed (Djavaheri-Mergny et al., 2007). Autophagy was involved 
in this pathway by the finding that siRNA knockdown of two proteins known to regulate 
autophagy, beclin1 and Atg7, reduced cell death (Ichimura et al., 2000; Liang et al., 1999). 
In another study, autophagy was implicated in the death of lipopolysaccharide 
(LPS)-activated macrophages. Treatment of these cells with the caspase inhibitor Z-VAD 
blocked classic apoptosis but nevertheless induced cell death in a caspase-independent 
pathway, suggested to involve autophagy (Xu et al., 2006). In addition, Bcl-2 directly 
associates with Beclin-1-suppressing autophagy (Luo and Rubinsztein, 2010). Bcl-2 also 
contributes to the regulation of the type III PI3-K and autophagy through attenuating ROS 
production. Hence, Beclin-1 regulates autophagy through integration of signals from many 
pathways in response to ROS (Lipinski et al., 2010). Therefore, ROS can regulate 
autophagy, depending on the severity of oxidative stress, suggesting regulation of 
intracellular redox status that controls autophagy (Yang et al., 2008). 
A role for autophagy in response to ROS is highlighted by the accumulation of oxidized 
proteins in aged cells under normal growth conditions, where autophagic pathways are 
compromised in age-related disorders, such as Alzheimer’s disease and diabetes mellitus 
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with a decrease in autophagy (Donati et al., 2001). Although autophagy is largely 
considered nonselective, preferential autophagy of damaged or excess organelles, such as 
peroxisomes (Farre and Subramani, 2004), endoplasmic reticulum (ER) (Bernales et al., 
2006; Kruse et al., 2006) and mitochondria (Lemasters, 2005), can occur and there is 
accumulating evidence for selective autophagic processes in response to ROS.      
 
Figure 4. Regulation of autophagy by ROS in normal cells. Intracellular ROS are generated by Nox 
(cytoplasmic) or by the mitochondrial. ROS can increase expression of Beclin-1 by an unknown 
mechanism, leading to autophagy. H2O2 can directly inactivate the cysteine protease Atg4, blocking the 
delipidation of Atg8 to induce autophagy. Selective autophagic degradation of catalase serves as a 
positive-feedback loop, causing accumulation of ROS, which further enhances autophagy. Other 
regulators of autophagy include the Akt/mTOR pathway, oncogenes Bcl-2/Bcl-xL, and tumor 
suppressors PTEN/p53. (Adapted from Azad, 2009) 
 
                                 1.9 Crosstalk between autophagy and apoptosis 
Both autophagy and apoptosis are important for the development and prevention of 
human diseases. They have been shown to act in synergy and also to counter each other. In a 
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clinical setting, one cannot predict the outcome of inhibition or activation of one death 
program without considering the effect on the other. Under certain conditions, autophagy 
and apoptosis are two independent processes, whereas in other situations, the activation of 
autophagy inhibits apoptosis (Platini et al., 2010) or autophagy occurs upstream of apoptosis 
(Eisenberg-Lerner et al., 2009). Several Atg proteins have been implicated in apoptosis. For 
instance, death-associated protein kinase (DAPK) has been proposed to convert autophagy 
from a cell survival mechanism to one of the initiation of cell death (Bialik and Kimchi, 
2010).  Caspase 3 cleaves the human Atg4 family member Atg4D to generate a truncated 
product, △ N63 Atg4D that, when overexpressed, induces autophagy-independent 
apoptosis (Betin and Lane, 2009). Furthermore, regulators of apoptosis, such as Bcl-2 
family members (Bcl-2 and Bcl-xL) (Betin and Lane, 2009), CASP8 and FADD-like 
apoptosis regulator (CFLAR) can regulate autophagy, and proteins involved in autophagy, 
such as Atg5, beclin 1 and Atg4D, can also have a role in apoptosis (Fimia and Piacentini, 
2010). Caspases also cleave Beclin 1 at Asp149 during apoptosis resulting in the inhibition 
of autophagy (Djavaheri-Mergny et al., 2010; Luo and Rubinsztein, 2010; Wirawan et al., 
2010). It remains to be investigated whether other Atg proteins are also cleaved during 
apoptosis. 
In mammalian cells, Bcl-2 family members in the outer mitohondrial membrane 
modulate autophagy. Bcl-2 downregulation increases autophagy in a caspase-independent 
manner in human leukemic HL60 cells (Saeki et al., 2000), and Bcl-2 overexpression 
inhibits both autophgy and caspase-independent death in growth factor-deprived neural 
progenitor cells and in serum- and potassium-deprived cultured cerebellar granule cells 
(Canu et al., 2005). Recent evidence suggests that Bcl-2 inhibits autophagy through a direct 
interaction with Beclin 1 and that the interaction between them may function as a rheostat 
that maintains autophagy at levels that are compatible with cell survival rather than cell 
death (Pattingre et al., 2005). In contrast, Bcl-2 or Bcl-xL overexpression potentiates 
autophagy and autophagy gene-dependent death in MEFs treated with the proapoptotic 
stimulus etoposide (Shimizu et al., 2004). The basis for the opposite effects of Bcl-2 family 
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members on autophagy in different settings is unclear. Furthermore, it is not yet clear that 
Bcl-2 proteins function at the mitochondrion to regulate autophagy, since autophagy is 
inhibited by Bcl-2 targeted to endoplasmic reticulum but not by Bcl-2 targeted to 
mitochondria (Pattingre et al., 2005). 
 
Figure 5. Overview of the molecular mechanisms underlying the autophagy-apoptosis crosstalk. There 
are three mechanistic paradigms of apoptosis that regulated by autophagy: (1) specific autophagy proteins; 
(2) autophagosomes as platforms for caspase activation; (3) autophagic degradation. Stimulatory 
interactions are depicted in blue, whereas inhibitory interactions are depicted in red. PPI, protein–protein 
interaction; MOMP, mitochondrial outer-membrane permeabilization. (Adapted from Rubinstein, 2012) 
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                      1.10 Therapeutic potential of Tranditional Chinese Medicine 
A large body of evidence indicates that in traditional Chinese medicine (TCM) a 
plethora of herbs and herbal extracts are effective in the treatment of vascular diseases such 
as chronic wounds, diabetic retinopathy and rheumatoid arthritis (Shu et al., 2010; Zhai et 
al., 2013). Thus, it seems rational to explore these medicinal plants as potential sources of 
novel angiomodulatory factors. Rhodiola is a widely used TCM herb that has been shown to 
improve cognitive function, reduce mental fatigue, promote free radical mitigation, and 
enhance learning and memory (Darbinyan et al., 2000; De Bock et al., 2004; Shevtsov et al., 
2003; Spasov et al., 2000). Rhodiola extracts exert anti-arrhythmic activity, show 
anti-inflammatory and neuroprotective effects, and prevent ischemia-reperfusion-induced 
ventricular tachycardia (Maslov et al., 2009; Qu et al., 2012; Sun et al., 2012). Salidroside 
(SAL), the major phenylpropanoid glycoside and pharmacological active constituent 
derived from Rhodiola, possesses potent anti-apoptotic effects in various cell types, e.g. 
neurons and cardiomyocytes as well as in preclinical disease models, e.g. acute myocardial 
infarction in rats (Qu et al., 2012; Zhong et al., 2010). Furthermore, SAL attenuated early 
ischemic brain injury, improved acute behavioral dysfunctions caused by focal cerebral 
ischemia, and protected against cerebrovascular injuries (Shi et al., 2012).          
Salvianolic acid B (SalB), a pure water-soluble compound extracted from Danshen, is 
known for its broad pharmacological potential, including neuro- and cardioprotective 
properties by inhibiting the lipid peroxidation and superoxide anion production (Chen et al., 
2000; Tang et al., 2002). SalB may furthermore suppress platelet aggregation, inhibit tumor 
necrosis factor-α-induced matrix metalloproteinase-2 upregulation, improve coronary 
microcirculation and cerebral blood flow, as well as inhibit myocardial ischemia (He et al., 
2008; Li et al., 2004; Pan et al., 2011; Zhang and Wang, 2006). Sal B also regulates vascular 
homeostasis by exerting a number of vasoprotective effects, including the stimulation of 
vasodilation, suppression of smooth muscle cell proliferation, and inhibition of 
inflammatory responses (Chen et al., 2011; Pan et al., 2012; Shou et al., 2012). However, 
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the molecular mechanisms responsible for the putative antioxidant action mediated by SalB 
are poorly understood.  
Icariin (ICAR) is a major flavonoid isolated from the traditional oriental herbal 
medicine Epimedium koreanum Nakai, has been proven to exert a broad range of biological 
efficacy on osteoporosis, cardiovascular diseases, and immunological function regulation 
(He et al., 1995; Xin et al., 2003; Yin et al., 2005). It has been reported that ICAR possessed 
a vasodilatory effect on the coronary vessels of animals, which is involved in the inhibiting 
of Ca
2+
channels, and has cardioprotective effects during ischemia and reoxygenation (Zhang 
et al., 2000). ICAR also has the ability to prevent endothelial cells from damage induced by 
H2O2 through increasing the NO content and decreasing of caspase expression (Wang and 
Huang, 2005). Therefore, the discovery of molecules that regulate autophagy may be of 
great significance in the development of drugs for the treatment. 
Puerarin (PUER) is the main isoflavone glucoside extracted from Puerariae Radix, 
which comes from the kudzu root (Pueraria lobota (Wild.) Howe). Puerarin is widely 
prescribed for patients with cardio-cerebrovascular diseases in China and it has been 
reported to have therapeutic effects on hypertension (Zhang et al., 2011b), cerebral ischemia 
(Gao et al., 2009), myocardial ischemia (Zhang et al., 2006b), diabetes mellitus (Hsu et al., 
2003), arrhythmia (Zhang et al., 2011a), and arteriosclerosis (Yan et al., 2006). Puerarin 
also improves endothelial function by inhibiting cellular factors, such as adhesive molecules 
(Hu et al., 2010) and C-reactive protein (Yang et al., 2010), and stimulating endothelial 
nitric oxide synthase phosphorylation and nitric oxide production via activation of an 
estrogen receptor-mediated phosphatidylinositol 3-kinase/Akt- and calmodulin-dependent 
kinase II/AMP-activated protein kinase- dependent pathway. The molecular mechanism 
underlying these pharmacological benefits are also believed to involve the decreases in the 
plasma levels of free fatty acids, matrix metalloproteinases-9, interleukin-6, and tumor 
necrosis factor-α, and the inhibition in inflammation and stabilization in the atherosclerotic 
plaque (Xiao et al., 2011; Yang et al., 2010; Yao et al., 2012).  
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Figure 6. Chemical structure of Salidroside (SAL), Salvianolic acid B (SalB), Icariin (ICAR), Puerarin 
(PUER). 
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2. MATERIALS AND METHODS 
 
2.1 Materials                                                                                                                              
2.1.1 Cell derivation 
Informed consent for bone marrow collection was obtained from healthy volunteers (8 
donors, age range 20-51 years, mean age 28.6 years) and all procedures were performed in 
accordance with the guidance and approval of the local institutional review board (approval 
no. EK263122004).   
 
2.1.2 Antibodies 
Table 1. List of antibodies. 
ANTIGEN COMPANY CAT.NR. APPLICATION DILUTION 
Phospho-Akt  Cell signaing  #4060 WB 1 to 1000 
Akt Cell signaing  #4691 WB 1 to 1000 
Phospho-mTOR  Cell signaing  #5536 WB 1 to 1000 
mTOR Cell signaing #2983 WB 1 to 1000 
Phospho-p70S6K 
(Thr389) 
Cell signaing #9234 WB 1 to 1000 
Phospho-p70S6K 
(Ser371) 
Cell signaing #9208 WB 1 to 1000 
p70S6K Cell Signalling #2181 WB 1 to 1000 
PCNA Cell Signalling #13110 WB 1 to 1000 
Phospho-4EBP1  Cell signaing #2855 WB 1 to 1000 
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4EBP1 Cell signaing #9644 WB 1 to 1000 
Phospho-ERK1/2  Cell signaing #4370 WB 1 to 2000 
Phospho-JNK  Cell signaing #4668 WB 1 to 1000 
Phospho-p38 MAPK  Cell Signaling #4511 WB 1 to 1000 
ERK1/2 Cell signaling #4695 WB 1 to 1000 
JNK Cell Signaling #9258 WB 1 to 1000 
p38 MAPK Cell Signaling #9212 WB 1 to 1000 
Bcl-xL Cell Signaling #2764 WB 1 to 1000 
Bax Cell Signaling #2774 WB 1 to 1000 
CD34 eBioscience 25-0349-42 Flow cytometry 1 to 1000 
CD133 Miltenyi Biotec 130-098-826 Flow cytometry 1 to 1000 
KDR Miltenyi Biotec 130-098-905 Flow cytometry 1 to 1000 
E-seclectin  BD Biosciences 551145 Flow cytometry 1 to 500 
vWF Abcam Ab9378 Flow cytometry 1 to 250 
VE-cadherin BD Biosciences 560411 Flow cytometry 1 to 500 
Cleaved-caspase 3 Cell Signaling #9664 WB 1 to 1000 
Cleaved-PARP Cell Signaling #5625 WB 1 to 1000 
Phospho-MKK3/6 Cell Signaling #9236 WB 1 to 1000 
MKK3 Cell Signaling #5674 WB 1 to 1000 
Phospho-ATF2 Cell Signaling #5112 WB 1 to 1000 
ATF2 Cell Signaling #9226 WB 1 to 1000 
Cytochrome c  Cell Signaling #4280 WB 1 to 500 
LC3B Sigma Aldrich  #9664 WB 1 to 1000 
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p62/SQSTM1  NOVUS NBP1-48320 WB 1 to 4000 
Beclin1 Cell Signaling #3761 WB 1 to 1000 
ß-actin Cell Signaling #4970 WB 1 to 2000 
GAPDH Sigma Aldrich  T9026  WB 1 to 5000 
HRP-conjugated 
secondary antibody 
Cell Signaling #7074 WB 1 to 2000 
DyLight® 594 
conjugated 
secondary antibody 
Abcam Ab96921 IF 1 to 800 
 
2.1.3 Buffers and culture medium 
For Biochemistry: 
 
1×RIPA (Radioimmunoprecipitation) Lysis Buffer  
0.1% PMSF in DMSO 
0.15 % protease inhibitor cocktail in DMSO 
0.1% sodium orthovanadate in water 
in 1× lysis buffer  
 
5× Protein loading buffer 
50% 500 mM Tris·HCl（pH6.8） 
4% ß-Mercaptoethanol 
5 mg/ml Bromophenol Blue 
100 mg/ml Sodium dodecyl sulphate 
50% Glycerol 
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10× TBE (Tris/Borate/EDTA) buffer 
0.5 M Tris 
0.5 M Boric Acid 
20 mM EDTA 
pH 8.0 
in ddH2O 
 
10× TBS-T (Tris buffered saline-Tween) 
1.5 M NaCl 
0.5 M Tris-HCl 
1% Tween 
pH 7.6 
in ddH2O 
 
1×Electrophoresis buffer 
25 mM Tris-HCl 
250 mM Glycine  
3.5 mM Sodium dodecyl sulphate 
in ddH2O 
 
1×Transfer buffer 
25 mM Tris-HCl 
192 mM Glycine 
20% Methanol 
in ddH2O 
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Stripping buffer 
700 μM ß-Mercaptoethanol 
2% Sodium dodecyl sulphate 
62.5 mM Tris·HCl（PH 6.7） 
in ddH2O 
 
Blocking buffer 
5% non-fat powder milk 
in TBS-T 
 
Antibody incubation buffer 
1% non-fat powder milk  
in TBS-T 
 
10×Ponceau S buffer 
2% Ponceau S 
30% Trichloroacetic acid 
30% Sulfosalicylic acid 
in ddH2O 
 
10% Resolving gel (10mL) 
30% Acrylamide 3.3 mL 
1.5 M Tris-HCl (PH 8.8) 2.5 mL 
10% Sodium dodecyl sulphate 0.1 mL 
10% Ammonium persulfate 0.1 mL 
TEMED 4 μL 
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ddH2O 4 mL 
 
4% Stacking gel (4 mL) 
30% Acrylamide 536 μL 
0.5 M Tris-HCl (PH 6.8) 1 mL   
10% Sodium dodecyl sulphate 40 μL 
10% Ammonium persulfate 40μL 
TEMED 4 μL 
ddH2O 2.4 mL 
 
For cell culture: 
Culture media 
Endothelial Cell Growth Medium 
Fetal Calf Serum 0.02 mL/mL 
Epidermial Growth Factor (recombinant human) 5 ng/mL 
Basic Fibroblast Growth Factor (recombinant human) 10 ng/mL 
Insulin-like Growth Factor (Long R3 IGF) 20 ng/mL 
Vascular Endothelial Growth Factor 165 (recombinant human) 0.5 ng/mL 
Ascorbic Acid 1 μg/mL 
Heparin 22.5 μg/mL 
Hydrocortisone 0.2 μg/mL 
100 U/ml of penicillin/streptomycin 
 
10× PBS (Phosphate buffered saline) 
1.37 M NaCl 
27 mM KCl 
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80 mM Na2HPO4 
17.6 mM KH2PO4  
pH 7.4 
in ddH2O 
 
Cryoprotectant solution 
10% DMSO  
90% fetal bovine serium 
 
For immunofluorescence: 
Permeabilization-blocking buffer 
5% Normal Goat Serum  
0.2% Triton-X-100 
in PBS 
 
Antibody incubation buffer 
3% Normal Goat Serum  
0.1% Triton-X-100 
in PBS 
 
2.1.4 Chemicals, dyes and kits 
Endothelial Cell Growth Medium 2 was purchased from PromoCell. Salidroside (SAL), 
Salvianolic acid B (SalB), Icariin (ICAR) and Puerarin (PUER) were obtained from Tauto 
Biotec. PicoGreen dsDNA Quantitation Kit was obtained from Life Technologies. Human 
basic fibroblast growth factor (bFGF) and VEGF ELISA kit were purchased from Peprotech. 
Nitric oxide colorimetric assay kit was obtained from Biovision. Hoechst 33258, DAPI and 
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Alexa Fluor 488
®
 phalloidin were obtained from Invitrogen. RNeasy Mini kit was obtained 
from Qiangen. Matrigel™ Basement Membrane Matrix and human fibronectin were 
obtained from BD Biosciences. 2’,7’-Dichlorofluorescin diacetate, diphenyleneiodonium 
chloride (DPI), Rhodamine 123, N
G
-nitro-L-arginine methyl ester (L-NAME), acridine 
orange, specific siRNAs targeting human 4EBP1 (MISSION® siRNA, 
SASI_Hs02_00336903), specific siRNAs targeting human ATF2 (MISSION® siRNA, 
SASI_Hs01_00147372), negative control siRNA, and MISSION® siRNA Transfection 
Reagent were purchased from Sigma Aldrich. Ficoll-Paque PLUS 1.077, hydrophobic 
PVDF membrane, ECL Plus Western Blotting Detection Reagents were obtained from GE 
healthcare life sciences. Specific primer-probe sets for VEGF, KDR, VE-cadherin, vWF, 
PECAM-1, Nox4, STAT-3, eNOS and GAPDH, High Capacity cDNA Reverse 
Transcription Kit and Two Step TaqMan® Fast Universal PCR Master Mix were purchased 
from Applied Biosystems. LY294002, U0126, SP600125 were obtained from Cell Signaling. 
SB2003580 was ordered from Calbiochem. Rapamycin was ordered from Santa Cruz. 
LIVE/DEAD viability/cytotoxicity kit was purchased from Invitrogen. Cytotox 96® 
non-radioactive cytotoxicity assay kit was purchased from Promega. Annexin V-FITC 
apoptosis detection kit was obtained from Miltenyi. Dihydroethidium (DHE) was ordered 
from Cayman Chemical. NADP/NADPH Assay kit was obtained from AAT Bioquest. 
 
2.2 Methods 
2.2.1 Isolation and cultivation of human bone marrow-derived endothelial progeinitor 
cells (BM-EPCs) 
Bone marrow sample was diluted with equal volume of DPBS, then the diluted sample 
was carefully layered onto the Ficoll-Paque PLUS. Centrifuge at 400×g for 20 min with the 
brake off. The mononuclear cells were carefully harvested from the interface between the 
Ficoll-Paque PLUS and sample buffer using a sterile pasteur pipette, and transfered to 
sterile centrifuge tubes. Cells were washed with an equal volume of DPBS twice to remove 
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the Ficoll-Paque PLUS residue. After washing, the isolated mononuclear cells were 
cultivated in flasks coated with human fibronectin (25 μg/mL) and induced by EGM-2 
medium at 37°C with 5% CO2 in humidified air at a density of 3-5×10
6
/cm
2
. After 3 d in 
culture, non-adherent cells were removed by washing with phosphate-buffered saline (PBS), 
new medium was applied and the cultivation was maintained through 7 d. 
 
2.2.2 Characterization of BM-EPCs 
Quantitative fluorescence-activated cell sorting (FACS) was performed on a vantage 
SE flow cytometer to detect the surface marker of CD34, CD133, KDR, VE-cadherin, 
E-selectin, vWF on the cells at 7 and 14 d. The Weibel-Palade body in cells was visualized 
by transmission electron microscopy (TEM). Immunofluorescence staining was performed 
using FITC-UEA-I and Dil-acLDL.  
 
2.2.3 Analysis of cellular proliferation 
BM-EPCs were seeded at a density of 6×10
3
 cells per well in 96-well plates, cultured 
with EGM-2 for 24 h followed by a starvation period of 24 h in EGM-2 without fetal bovine 
serum (FBS). Then medium was replaced by fresh non-FBS EGM-2 containing different 
concentrations of TCM extracts and cells were incubated for an additional period of 1, 2, 
and 4 d. After the samples were washed once with PBS and lysed in PBS containing 0.1% 
Triton X-100 for 50 min, DNA content was determined using the Quant-iT PicoGreen 
dsDNA Assay Kit according to the manufacturer’s instructions. Fluorescence was measured 
using a fluorescence microplate reader (SpectraFluorPlus, Tecan, Männedorf, Switzerland) 
at 480/520 nm wavelength. Triplicates were used for each experimental unit. 
 
 
39 
 
2.2.4 Cell migration (chemotaxis) assay  
Here we have adopted two methods to investigate the TCM extracts-induced migratory 
activity of human BM-EPCs in a transwell assay (6.5 mm diameter, 8 µm pore size filters). 
First, cells were cultivated for 7 d with EGM-2, trypsinized and counted. A fraction of 
8×10
4
 cells in 200 µL non-FBS EBM-2 were seeded into the upper chamber while 700 µL 
of culture medium containing 1% FBS and different concentrations of TCM extracts were 
placed in the lower chamber. The EPCs were allowed to migrate for 4 h at 37°C in the tissue 
culture incubator. Second, BM-EPCs that were treated with TCM extracts for 48 h were 
trypsinized, washed and resuspended in EBM-2 without FBS. A fraction of 1×10
5
 cells in 
200 µL EBM-2 were added to the top chamber of a transwell and 700 µL EBM-2 with 5% 
FBS were added to the bottom chamber. Cells were allowed to migrate for 2 h. To quantify 
the number of migrated EPCs on the membrane, the upper side of the membrane was 
washed carefully with cold PBS and the remaining cells on this side were removed with a 
cotton swab. Transwell membranes were stained with Alexa Fluor 488
®
 phalloidin in PBS 
and the migrated cells were examined using an inverted fluorescence microscope (Apotome, 
Carl Zeiss, Germany). All experiments were performed in at least triplicate with cells 
counted in 10 random fields of view. 
 
2.2.5 Cell adhesion assay 
Cell-matrix adhesion assay 
Cell-matrix adhesion assay using human BM-EPCs was performed as was previously 
published (Tang et al., 2011). Briefly, 96-well plates were coated with 25 µg/mL human 
fibronectin for 1 h. Human BM-EPCs at 1×10
4 
cells per well in EGM-2 were plated onto 
fibronectin-coated 96-well culture plates and incubated for 30 min at 37°C. After washing 
twice with PBS, adherent cells were fixed with 4% paraformaldehyde, stained with Hoechst 
33258, and visualized under a fluorescence microscope. Additionally, adherent cells were 
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lysed with Triton X-100 and the DNA content was determined using the Quant-iT 
PicoGreen dsDNA Assay Kit. Representative results of five independent experiments were 
shown.  
Cell-cell adhesion assay 
To characterize the possible effect of TCM extracts on cell-cell adhesion, EPCs were 
grown overnight to a confluent monolayer in EGM-2 and labeled with Hoechst 33258. In 
addition, EPCs from the same donor were treated with TCM extracts for 48 h and 
fluorescence-labeled with calcein acetoxymethyl (AM) for 1 h at 37°C followed by washing 
with PBS. These cells were then plated onto the established cell monolayer (acceptor cells). 
Attachment and spreading of the plated cells were monitored and recorded after 20 min by 
fluorescence microscopy. Quantification of intercellular adhesion was performed by 
counting the number of cells per microscopic field of view that remained attached after 
three gentle washing steps with PBS.  
 
2.2.6 Matrigel-based capillary-like tube formation assay 
The effect of TCM extracts on morphogenesis and tube formation capacity of 
BM-EPCs was investigated using the capillary tube formation assay on Matrigel basement 
membrane matrix. Briefly, ECMatrix™ solution was thawed on ice overnight, mixed with 
10× ECMatrix™ diluents and placed in a 96-well tissue culture plate (50 µL per well) at 
37°C for 1 h to allow the matrix solution to solidify. A fraction of 1.2×10
4
 cells per well 
were seeded on a Matrigel-precoated 96-well plate. Tube formation was observed under an 
inverted light microscope. Five independent fields were assessed for each well and the 
average numbers of tubes per 40× magnified field were determined.  
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2.2.7 Enzyme-linked immunosorbent assay (ELISA) 
Cell culture supernatants were harvested 24 h and 48 h after stimulation with TCM 
extracts and frozen for later analysis. The levels of vascular endothelial growth factor 
(VEGF) secreted by BM-EPCs into the medium were measured by a commercially available 
ELISA kit. Briefly, capture antibody was diuted and added to a ELISA plate well and 
incubated overnight at room temperature (RT). After washing the plate for 4 times, 
immediately added 100 μL of standard or sample to each well in triplicate, incubated at RT 
for 2 h. The plate was aspirated and washed for 4 times. Detection antibody was added to 
each well and incubated at RT for 2 h. After washing for 4 times, substrate solution was 
added and incubated at RT for color development. The absorbance at 405 nm was measured 
with a microplate reader. 
 
2.2.8 Measurement of nitric oxide production of BM-EPCs 
Accumulated nitrite (NO2
−
) generated from cell-released nitric oxide (NO) in culture 
supernatants was determined using a spectrophotometric assay based on the Griess reaction. 
In brief, adherent cells were stimulated with TCM extracts for 2, 5, 8 and 10 d and cell 
culture supernatants were collected to demonstrate any time dependent effect. Supernatants 
were converted to nitrite by nitrate reductase followed by the Griess reagent (1% 
sulfanilamide - 0.1 % N-1-naphthyl-ethylenediamine dihydrochloride in 2.5% phosphoric 
acid) to convert nitrite to a deep purple azo compound. For determination of this compound 
the absorbance at 540 nm was measured with a microplate reader and all samples were 
tested in triplicate. 
 
2.2.9 Cellular viability and lactate dehydrogenase release assay 
BM-EPCs were treated with TCM extracts or basal medium for 48 h followed by 
incubation with 1 mM H2O2 for 6 h to induce oxidative stress. Cell numbers were 
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determined by DNA quantification as described above. Cells incubated without TCM 
extracts (in EBM-2 only) served as control group. 
Lactate dehydrogenase (LDH) is a stable cytosolic enzyme present in all cell types. 
The cellular viability can be measured in terms of LDH released from dead cells into the 
supernatant upon rupture of cell membrane. For this purpose, CytoTox 96
®
 
Non-Radioactive cytotoxicity assay kit was employed according to the manufacturer’s 
instructions. Briefly, 100 μL of lysis solution were added into wells containing the untreated 
control cells prior to the assay to induce maximum LDH release. To define the LDH content 
50 µL supernatant with 50 µL of substrate solution were mixed in 96-well plates. After 30 
min incubation at RT under absence of light, the enzymatic reaction was stopped with 50 µL 
stop solution. The absorbance was measured spectrophotometrically at 490 nm using a 
microplate reader. The percentage of cytotoxicity was calculated according to the following 
equation: 
percentage of cytotoxicity= 
                                  
                                
 ×100%.  
 
2.2.10 Assessment of intracellular ROS and superoxide production  
Intracellular ROS measurement by dichlorofluorescein (DCF) 
The assessment of ROS involves the use of 2’,7’-dichloro-ﬂuorescein diacetate, which 
is a stable non-fluorescent molecule that readily crosses cell membranes and is hydrolyzed 
by intracellular esterases to form non-fluorescent DCFH. DCFH is then rapidly oxidized in 
the presence of ROS into highly fluorescent DCF. Cells were incubated in fresh EBM-2 
containing 20 μM DCFH-DA for 30 min at 37°C. After removal of the 
DCFH-DA-containing medium, ROS formation was stimulated by H2O2 (final 
concentration: 1 mM) for 6 h at 37°C. Prior to and 6 h after H2O2 addition, the fluorescence 
levels of the samples were measured using a fluorescence microplate reader with the 
excitation and emission wavelengths set at 488 and 525 nm, respectively. 
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Superoxide measurement by dihydroethidium (DHE)  
Superoxide generation causes oxidation of DHE into ethidium bromide, which binds to 
DNA in the nucleus and fluoresces red. EPCs were treated with H2O2 in the presence or 
absence of TCM extracts as described above. The medium was then replaced by PBS 
containing DHE (10 μM) followed by incubation for 30 minutes at 37°C. The intensity of 
DHE fluorescence was acquired by fluorescence microplate readings and images were 
collected using a fluorescence microscope and analyzed by Zeiss Imaging System.  
 
2.2.11 Determination of NADPH oxidase activity  
NADP and NADPH were measured using an Amplite Fluorimetric NADP/NADPH 
Assay kit. Cells treated with TCM extracts as well as untreated cells were lysed with 0.5% 
Triton-X100 for 10 min at RT and then mixed with 50 μL NADPH reaction mixture to a 
total volume of 100 μL per well. After incubation for 90 min at RT absorbance was 
monitored at 575 nm using the microplate reader. 
 
2.2.12 Measurement of mitochondrial membrane potential 
Measurement of the mitochondrial membrane potential (ΔΨm) was performed by 
loading cells with 5 µM Rhodamine123, a cationic lipophilic fluorochrome that can be taken 
up by mitochondria in proportion to the ΔΨm. After 20 min incubation in the dark, the cells 
were washed twice with PBS immediately followed by fluorescence reading at 507/529 nm 
(ex/em). 
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2.2.13 Calcein AM/ Ethidium homodimer-1 cellular viability assay 
Cell viability was determined using a calcein-AM/Ethidium homodimer-1 (EthD-1) 
dual-staining assay kit (Invitrogen). This assay relies on the intracellular esterase activity 
within living cells, through which the calcein-AM, a cell permeable fluorogenic esterase 
substrate, hydrolyzes to the green fluorescent product calcein. Dead cells are stained by the 
cell-impermeant indicator EthD-1, which is a high-affinity nucleic acid stain that is weakly 
fluorescent until bound to DNA and emits red fluorescence. The cell cultures were treated 
with or without 1 mM H2O2 for 6 h after TCM extracts stimulation. After treatment, the 
culture medium was removed, and cells were rinsed with warm PBS very gently as not to 
stir cells. Subsequently 2 μM calcein-AM and 4 μM EthD-1 in 100 µL PBS were added to 
each culture well and incubated at 37°C for 30 min, and fluorescence signals of the cells 
were observed under a Zeiss fluorescence microscope. 
 
2.2.14 Apoptosis assay with flow cytometry analysis 
BM-EPCs were seeded in six-well plates and allowed to attach for 24 h. After 48 h of 
treatment with SAL and 6 h of induction by H2O2 as described above, cell apoptosis was 
detected by annexin V-FITC apoptosis detection kit following the manufacturer’s 
instructions. Briefly, the cells were gently trypsinized, washed with PBS, re-suspended in 
binding buffer and incubated with annexin V-FITC and PI at RT in the dark for 10 min, and 
then measured immediately by Flow Cytometer (BD™ LSRII, Heidelberg, Germany). The 
analysis of the data was performed using FlowJo Software (Tree Star, Inc., Ashland, OR, 
USA). 
 
2.2.15 Immunofluorescence 
To confirm the results of the apoptosis assay, immunofluorescence stain for Bax and 
Bcl-xL was used. The cells were fixed with 4% paraformaldehyde for 20 min at RT and 
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washed three times in PBS buffer. Fixed cells were blocked by incubation in PBS with 5% 
normal goat serum and 0.2% triton X-100 at RT for 30 min. Then the cells were incubated 
with primary antibody overnight at 4°C. After cells were washed three times with PBS, they 
were incubated with red-fluorescent Alexa Fluor 594 secondary antibody for 1 h at 37°C. 
Finally, these cells were stained with DAPI at RT for 10 min. The stained cells were washed 
three times with PBS. The results were visualized using fluorescence microscopy (Apotome, 
Carl Zeiss, Oberkochen), with fluorescence filter set at 488 nm (green) and 570 nm (red).  
 
2.2.16 Acridine orange staining 
Acidic intracellular compartments were visualized by acridine orange staining. After 
treatment, cells were washed with PBS and stained with 10 mg/mL acridine orange for 15 
min at 37°C. Microscopic images were collected using the fluorescence microscope. 
Depending on their acidity, autophagic lysosomes appeared as orange/red fluorescent 
cytoplasmic vesicles, while the nuclei were stained green. 
 
2.2.17 Small interference RNA transfection 
Specific siRNAs targeting human ATF2 and 4EBP1 were obtained from Sigma-aldrich. 
The cells were transiently transfected with a negative control siRNA or ATF2 (or 4EBP1) 
siRNA using the MISSION® siRNA Transfection Reagent. Cellular levels of the proteins 
specific for the siRNA transfection were checked by qRT-PCR and Western blot, the cells 
were then prepared for further experiments at 48 h after transfection. 
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2.2.18 RNA isolation, cDNA synthesis and quantitative real-time polymerase chain 
reaction (qRT-PCR) procedure 
Total RNA was isolated by using RNeasy Mini Kit. Total RNA (300 ng) from each 
sample was subjected to reverse transcription using a cDNA reverse transcription kit. For 
the reverse transcription, typical 20 µL reactions contained 2 µL 10×RT Buffer, 0.8 µL 
25×dNTP Mix, 2 µL 10×RT Random Primers, 1 µL MultiScribe Reverse Transcriptase, 1 
µL RNase Inhibitor, 3.2 µL Nuclease-free H2O, and 10 µL RNA sample. Thermal cycling 
conditions were: 25°C for 10 min, 37°C for 120 min and finally 85°C for 5 min. The ABI 
Prism 7500 fast Sequence Detection System was used for the qRT-PCR. Typical 20 µL 
reactions contained 10 µL ABI fast Universal TaqMan Master Mix, 1 µL mixture of 
forward and reverse primers and TaqMan probe, 1 µL cDNA and 8 µL water. Each PCR run 
was performed in triplicate including negative control samples containing master mix, 
primers and probes as described above but no cDNA template. Thermal cycling conditions 
of the ABI 7500 fast were: 95°C for 20 s for pre-denaturation, then 40 cycles of 95°C for 3 s 
and finally 60°C for 30 s each. Data were normalized to GAPDH expression and fold 
change was calculated by the 2
−ΔΔCT
 method. 
 
2.2.19 Western blot analysis 
Whole-cell lysates of cell groups were analyzed by Western blot assays. Cells were 
washed twice with PBS, sonicated in radioimmunoprecipitation (RIPA) buffer and 
homogenized. Debris was removed by centrifugation at 12,000 g at 4°C for 10 min and 
protein concentration was determined using the BCA Protein assay kit according to the 
manufacturer’s instructions. Samples containing 30 µg of protein were separated by 
electrophoresis on sodium dodecyl sulfate (SDS) polyacrylamide gels and transferred to 
polyvinylidene difluoride membranes by electroblotting. The membranes were then blocked 
by incubating with 5% BSA in 20 mM Tris-HCl, 150 mM NaCl, pH 7.5 (TBS) buffer for 1 
h followed by incubation with primary antibodies (see Materials section, 2.1.2 Antibodies for 
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a detailed list and conditions), overnight at 4°C. After washing with TBS-T, membranes 
were incubated with horseradish peroxidase-conjugated secondary antibodies, diluted in 
incubation buffer, for 2 h at RT. After washing with TBS-T, luminescence was developed 
using an automated developer (Sysgen) and non saturated radiograms analyzed with 
Quantity One 4.6.2 software (Bio-Rad Laboratories, Hercules, CA, USA). GAPDH or 
ß-actin were used for internal normalization. 
 
2.2.20 Animal study 
For in vivo study, 2 mg SAL was embedded into 5 µL gel (25 mg/mL Fibrinogen and 
25 IU/mL Thrombin, 1:1) to make the final concentration of 50 mg/kg body weight. The 
operations were performed under surgical aseptic conditions. Each immunodeficient mouse 
was placed in the prone position. The right rear extremity was extended and rotated inward 
at the hip joint. Exact locations of the hip and knee joints were detected by flexion and 
extension of the hip and of the knee. A 12-mm incision was then performed along the lateral 
upper leg, giving exposure to the greater trochanter. An incision was then made along the 
fascia lata, following a line from the greater trochanter to the knee joint. The quadriceps 
femoris muscle was mobilized anteriorly towards the knee and the hip using two spatulas. A 
sharp elevatorwas used to expose the distal femur and the first hole (diameter 0.45 mm) was 
drilled into the distal femur. The first pin was put into one of the lateral holes of the plastic 
body of the external fixation device and was subsequently orthogonally drilled into the 
distal femur, penetrating both the lateral and the medial cortex. The second hole was drilled 
through the remaining lateral hole on the plastic body and into the proximal femur or the 
lateral femoral neck as described above. The second pin was then placed through this hole. 
The inner two pins were then placed after drilling the inner two guide holes. After having 
fixed all four pins, two Gigli wires were placed around the femur and placed into the fixed 
saw guide on the body of the external fixator. A defect was cut using two Gigli wires while 
the body of the fixation device was stabilized with the help of two clamp. The Fibrinogel 
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(10 μL) containg SAL were laid on the mineralized collagen scaffold and embedded 
between the fixed pins. The clamps were then removed and the femur and surrounding 
structures were all guided back into their natural anatomic positions. Finally, the skin was 
closed with interrupted sutures. To investigate bone healing during the 6-week observation 
period, 20-mm data sets of all operated and six untreated contralateral femurs were scanned 
using μCT (SCANCO viva CT 75; SCANCO Medical AG, Bruttisellen, Switzerland). The 
defect volume reported is the difference of the bone volume of the control femurs, BMP-2 
treated femurs, and the SAL treated femurs. 
 
2.2.21 Statistical analysis 
Numerical data are presented as the means ± standard deviation from at least three 
individual experiments with cells from different donors, unless otherwise indicated. All 
statistical analysis were performed using the SPSS 16.0 software package. Comparisons 
between two groups were performed using independent-samples t-test. Experiments with 
more than two groups were compared by ANOVA followed by the Tukey post-hoc test. P 
values of ≤ 0.05 were considered statistically significant 
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3. RESULTS 
3.1 TCM extracts induce angiogenic differentiation in bone marrow 
derived-endothelial progenitor cells 
3.1.1 Cultivation and identification of BM-EPCs 
When mononuclear cells isolated from human bone marrow were cultured in 
endothelial cell growth medium on fibronectin-coated dishes, both adherent and 
non-adherent cells demonstrated round morphology with different sizes as assessed by light 
microscopy during the first 3 d, suggesting the presence of various subpopulations within 
the human mononuclear cell fraction. Approximately 20% of the mononuclear cells 
transferred to culture plates grew as adherent cells during the first week of culture with a 
tendency to form clusters or colonies (Figure 7A). When cultivated for 7 d, the adherent 
cells exhibited strong ability to take up Dil-acLDL and FITC-UEA-I, and the double 
positive rate was (95.1 ±4.0)% (Figure 7B), which were identified as differentiating EPCs. 
The Weibel-Palade body was observed in endochylema by TEM (Figure 7C). During the 
second week of culture, the cells changed toward a spindle-shaped endothelium-like 
morphology. Then, attached cells formed a cobblestone-like structure at d 14 (Figure 7A). 
In the culture process, the expression pattern of surface markers changed toward a more 
mature endothelial cell phenotype during the cultivation period of 2 weeks, which showed a 
significant increase when 14 d cultures were compared to 7 d cultures with regard to the 
expression of KDR (from 66.7% to 79.2%), E-selectin (from 7.8% to 46.4%), vWF (from 
5.4% to 35.4%), and a marked decrease in expression of CD133 (from 18.5% to 3.8%), and 
CD34 (from 45.4% to 36.1%) (Table 1). 
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Figure 7. Characterization of BM-EPCs. (A) The isolated mononuclear cells were cultivated in dishes 
coated with fibronectin and induced by EGM-2 at 37 °C with 5% CO2 in humidified air. The morphology 
of the cells cultivated at 7 d, 11 d, and 14 d was observed under the inverted phase contrast microscope. 
(B) Cells cultivated at 7 d were washed with PBS two times, and stained with FITC-UEA-I and 
Dil-acLDL. (C) The Weibel-Palade body in cells was visualized by transmission electron microscopy 
(TEM).  
Table 2.The expression pattern of cell surface markers of CD133, CD34, KDR, VE-Cadherin, E-selectin 
and vWF was determined by flow cytometry at 7 d and 14 d culture. Data are shown as mean ± SD. 
 
3.1.2 SAL, ICAR and PUER promote the cellular proliferation of BM-EPCs 
To assess the potent pro-angiogenic property of TCM extracts in vitro, we firstly 
examined the effect of TCM on cellular proliferation. Human BM-EPCs were treated with 
varying concentrations of SAL, SalB, ICAR and PUER for 24 h, 48 h and 96 h and cell 
number was assessed by DNA quantification with bFGF as a positive control. As shown in 
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Figure 8A, the cell number was apparently increased after the incubation with SAL for 48 h 
at the concentration of 20, 40, and 80 µM, with ICAR at 7.5, 15, 30 µM (Figure 8C), and 
with PUER at 40, 80 µM by both 24 and 48 h (Figure 8D). The protein expression of PCNA 
was also enhanced by 48 h incubation with SAL by 20, 40, and 80 µM (Figure 8E). But no 
significant effect was found at 24 h or 96 h treatment with SAL, compared to the control 
group. However, cell numbers were not significantly affected by SalB treatment (Figure 
8B).  
52 
 
 
Figure 8. Effect of SAL, SalB, ICAR and PUER on cellular proliferation of BM-EPCs. (A-D) Cells were 
treated with indicated concentrations of TCM extracts for 24, 48, and 96 h followed by DNA 
quantification to determine cellular proliferation, n=6. (E) PCNA expression was measured by Western 
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blot. The immunoblots shown are representative of at least three independent experiments with 
comparable results. Data are shown as mean ± SD, 
＊
P < 0.05, 
＊＊
P < 0.01 versus control group.  
 
3.1.3 SAL, SalB, ICAR and PUER enhance cell recruitment ability 
EPCs that line the lumina of blood vessels are important players in blood vessel 
formation, and directed EPCs migration is a key component of the angiogenic process. To 
investigate the effects of TCM extracts-driven motility in BM-EPCs, transwell experiments 
were performed. When TCM extracts were added to the lower chamber compartment, cells 
showed a dramatically increased ability to migrate in response to all of them in a dose 
dependent manner. For SAL, the significant promotion effect was first occurred at 40 μM 
(2.59 ± 0.07-fold, P < 0.01) and peaked at 80 μM (3.05 ± 0.10-fold, P < 0.01) (Figure 9B, 
9F). For SalB, the significant promotion effect was first occurred at 20 μM (1.80 ± 0.08-fold, 
P < 0.05), and peaked at 40 μM (1.92 ± 0.14-fold, P < 0.01) (Figure 9C, 9G). For ICAR, all 
of the three concentrations had remarkable effects on the chemotactic ability of BM-EPCs 
(7.5 μM, 2.79 ± 0.10-fold, P < 0.01; 15 μM, 4.15 ± 0.10-fold, P < 0.01; 30 μM, 4.95 ± 
0.07-fold, P < 0.01) (Figure 9D, 9H). For PUER, the enhancing effect were occurred from 
40 μM (1.82 ± 0.28-fold, P < 0.05), to 160 μM (3.05 ± 0.13-fold, P < 0.01) (Figure 9E, 9I). 
Interestingly, for experiments involving pre-treatment of EPCs with TCM extracts 
which were used to measure the ability of TCM extracts to trigger innate cell recruitment 
ability, the results showed that cell migration increased significantly compared to the 
vehicle-treated control at a higher concentration of 80 μM SAL (Figure 9J, P < 0.01), and 
15 μM and 30 μM of ICAR (Figure 9K, P < 0.05 and P < 0.01, respectively).  
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Figure 9. TCM extracts enhance cell migration capacity in a dose-dependent manner. (A-I) Transwell 
chemotaxis assay was performed on BM-EPCs with phosphate buffered saline (control), 50 ng/mL bFGF 
and indicated concentrations of TCM extracts in the lower chamber. To quantify the migrated EPCs on 
the membrane, the upper side of the membrane was washed and wiped with a cotton swab. Transwell 
membranes were stained with Alexa Fluor 488
®
 phalloidin and the migrated cells were examined using 
an inverted fluorescence microscopy. The number of migrated cells was quantified by performing cell 
counts of 10 random fields, n=5. (J, K) BM-EPCs were treated in the absence or presence of indicated 
concentrations of SAL, ICAR and bFGF for 48 h, then seeded into the upper chamber of the transwell 
with culture medium containing 5% FBS in the lower chamber. Data are presented as mean ± SD, n=5, 
＊
P < 0.05, 
＊＊
P < 0.01 versus control group.    
 
3.1.4 Effect of SAL, SalB, ICAR and PUER on cell adhesion to extracellular matrix 
(ECM) and cell-cell adhesion of BM-EPCs 
To test whether TCM extracts affect cell-matrix adhesion we used human fibronectin 
as ECM. As shown in Figure 10B and 10F, SAL treated cells attached more readily to the 
ECM (1.95±0.14-fold and 1.98±0.10-fold increase at 40 and 80 µM) compared to the 
control (P < 0.01). Similarly, ICAR also promoted the cell-matrix adhesion at all of the 
three concentrations (7.5 μM, 1.70 ± 0.12-fold, P < 0.01; 15 μM, 2.40 ± 0.08-fold, P < 0.01; 
30 μM, 2.78 ± 0.15-fold, P < 0.01, Figure 10D, 10H). In addition, PUER-treated cells 
showed an enhancing ability to adhere to the ECM at higher concentrations (1.91±0.09-fold 
and 2.19±0.14-fold increase at 80 and 160 µM, P < 0.01, Figure 10E, 10I). But there was no 
significant difference concerning the number of attached cells after 90 min adherence. 
However, SalB have shown no significant effect on the cell-matrix adhesion (Figure 10C, 
10G). 
To investigate whether TCM extracts could affect cell-cell adhesion of BM-EPCs, we 
examined the adherence of TCM extracts-stimulated cells to normal EPCs. In sharp contrast, 
a significant reduction in the adhesive properties was observed for SAL and ICAR-treated 
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BM-EPCs, which became apparent at 20 µM and peaked at 80 µM for SAL (Figure 10J-M), 
and showed effect at both 15 µM and 30 µM for ICAR (Figure 10L, 10N). Taken 
together, these results suggest that TCM extracts provoked the cell adhesive ability to ECM, 
while it diminished the capacity of cell-cell adhesion.    
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Figure 10. SAL, ICAR and PUER promote cell-matrix adhesion but SAL, ICAR inhibit cell-cell 
adhesion of BM-EPCs. (A-E) BM-EPCs were treated with indicated concentrations of TCM extracts or 
bFGF for 2 d. Cell adhesion to extracellular matrix was performed on fibronectin treated plates for 30 
min followed by staining of adherent cells with Hoechst 33258 dye (nuclei, blue). (F-I) Quantification of 
attached cells was determined by DNA content using Quant-iT PicoGreen dsDNA Assay Kit. Data are 
presented as mean ± SD, n=5. (J-N) For the examination of cell-cell adhesion, BM-EPCs were grown 
overnight to a confluent monolayer in EGM-2 and labeled with Hoechst 33258 dye. Another set of 
BM-EPCs was treated with indicated concentrations of TCM extracts or bFGF for 48 h, 
fluorescence-labeled with calcein-AM for 1 h, and plated onto the established cell monolayer. 
Quantification of cell-cell adhesion was performed by counting the number of cells per microscopic field 
of view that remained attached after 20 min incubation. Data are presented as mean ± SD, n=5, 
＊
P < 
0.05, 
＊＊
P < 0.01 versus control group.   
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3.1.5 Effect of SAL, SalB, ICAR and PUER on capillary tube formation of BM-EPCs 
in vitro 
In vitro angiogenesis assay was used to investigate the ability of EPCs to participate in 
vascularization, which is the most important activity of EPCs. To determine whether TCM 
extracts affect the ability of BM-EPCs to form capillary-like tubes, cells were seeded on 
Matrigel and examined for tube formation microscopically. 18 h after plating onto the gel, 
more crosspoints and well formed connections were observed in the tubules formed by 
SAL-stimulated cells compared with control group (Figure 11A, 11B, 11F). The presence of 
20, 40 and 80 µM SAL significantly increased the number of sprouting tubules by 250.1 ± 
17.5%, 350.1 ± 18.8% and 525.4 ± 10.4% as compared with untreated BM-EPCs (P < 0.01). 
Moreover, 20 µM SalB significantly increased the number of sprouting tubules by 350 ± 13% 
as compared with untreated BM-EPCs. However, this effect was not observed at the 
concentration of 40 μM SalB (Figure 11C, 11G). Additionally, the presence of 7.5, 15 and 
30 µM ICAR significantly increased the number of sprouting tubules by 225.4.4 ± 25.6%, 
404.3 ± 19.9% and 598.1 ± 11.5% as compared with untreated BM-EPCs (Figure 11D, 11H). 
And PUER treatment also exerted enhanced capillary tube formation of the cells by 220.0 ± 
21.8% and 263.4 ± 21.2% at 80 and 160 µM (Figure 11E, 11I). Thus TCM extracts strongly 
enhance the ability of EPCs to form tube-like structures  
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Figure 11. Effect of SAL, SalB, ICAR and PUER on capillary tube formation of BM-EPCs. (A-E) After 
TCM extracts treatment cells were grown on MatrigelTM for 18 h under normal growth conditions, 
capillary tube formation was observed by inverted light microscopy. (F-I) Five independent fields were 
assessed for each well and the average numbers of tubes/40× magnified field were determined. Data are 
expressed as mean ± SD, n=5, 
＊
P < 0.05, 
＊＊
P < 0.01 versus control group. 
 
3.1.6 SAL and ICAR increase VEGF secretion and NO production in BM-EPCs 
In the light of the important role of VEGF and NO in the regulation of angiogenesis 
and cell function, we treated EPCs with SAL or ICAR at different concentrations, and 
determined VEGF and NO production in the cell supernatants. Over a period of 24 h and 48 
h incubation, SAL at both 40 μM and 80 μM enhanced the VEGF secretion by 
approximately 11.3% (24 h, 40 μM), 17.5% (24 h, 80 μM), 18.9% (48 h, 40 μM) and 21.0% 
(48 h, 80 μM) compared to respective controls (Figure 12A). ICAR enhanced the VEGF 
secretion in a time and concentration-dependent manner by 20.4% (24 h, 15 μM), 36.7% (24 
h, 30 μM), 23.8% (48 h, 15 μM) and 30.0% (48 h, 30 μM) compared to respective controls 
(Figure 12B). 
Moreover, NO production of BM-EPCs increased significantly when cells were 
stimulated by SAL or ICAR for 2, 5, 8, and 10 d (Figure 12C, 12D). These findings imply 
that the increased VEGF and NO production may play an important role in the enhanced 
tube formation ability of BM-EPCs induced by TCM extracts. Furthermore, we used 
N
G
-nitro-L-arginine methyl ester (L-NAME) which is a selective inhibitor of NOS to 
examine the role of NO underlying the angiogenic effect of SAL. As shown in Figure 12E, 
L-NAME could significantly inhibit SAL-induced NO production after 2 d 
incubation. Furthermore, the promotion effect of SAL on migration and capillary tube 
formation ability on EPCs were suppressed by L-NAME (Figure 12F, 12G). The present 
study further supports the notion that endothelium-derived NO plays a key role in 
angiogenesis. 
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Figure 12. SAL and ICAR enhance the secretion of VEGF and the production of NO in BM-EPCs. Cells 
were cultured until confluency in 96-well plates and subsequently stimulated with indicated 
concentrations of TCM extracts. (A, B) Cell culture supernatants collected after 24 h and 48 h VEGF 
secretion was determined by ELISA, n=5. (C, D) To assess NO production, cell culture supernatants were 
collected 2, 5, 8, and 10 d after SAL or ICAR stimulation and analyzed by Griess assay, n=4. (E) Cell 
culture supernatants were collected 48 h after SAL stimulation with or without 10 μM L-NAME, NO 
levels were measured by Griess assay, n=3. (F, G) BM-EPCs were treated with 10 μM L-NAME and 80 
μM SAL for 48 h. Cell migratory ability was evaluated by performing cell counts of 10 random fields, 
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n=4. Capillary-like tube formation were determined by assessing average numbers of tubes/40× 
magnified field, n=3. All data are presented as mean ± SD, 
＊
P < 0.05, 
＊＊
P < 0.01 versus control group. 
 
3.1.7 SAL, SalB and ICAR induce angiogenic gene expression in BM-EPCs 
To determine the underlying mechanism involved in the proangiogenic effects of TCM 
extracts, the expression of VEGF, KDR, eNOS, vWF, PECAM-1 and VE-cadherin were 
determined by quantitative RT-PCR. As shown in Figure 13A, the expression levels of 
VEGF, KDR, and eNOS significantly increased after 2 d (1.46 ± 0.24-fold, 1.96 ± 0.20-fold, 
2.82 ± 0.37-fold) and 10 d (1.61 ± 0.15-fold, 1.66 ± 0.22-fold, 3.18 ± 0.42-fold) 
pretreatment with 80 μM SAL. While vWF gene expression was enhanced after 2 d (1.79 ± 
0.22-fold) and 10 d (2.20 ± 0.29-fold) cultivation, PECAM-1 expression was increased only 
after 2 d (2.01 ± 0.18-fold) cultivation (Figure 13A). VE-cadherin expression was 
downregulated by 67.8% after 2 d and by 78.0% after 10 d with a similar trend for bFGF 
expression (Figure 13A). As shown in Figure 13B, the expression levels of VEGF, KDR, 
eNOS and PECAM-1 significantly increased after 2 d (2.27 ± 0.11-fold, 2.53 ± 0.06-fold, 
2.27 ± 0.12-fold, 1.83 ± 0.10-fold) (P < 0.01) and 10 d (2.37 ± 0.06-fold, 1.51 ± 0.16-fold, 
2.56 ± 0.15-fold, 1.84 ± 0.15-fold,) (P < 0.01) pretreatment with 20 μM SalB. In contrast, 
VE-cadherin expression was downregulated by 83.9% after 2 d and by 51.8% after 10 d. 
However, vWF gene expression was not affected by SalB administration. In Figure 13C, the 
expression levels of VEGF, KDR, and eNOS significantly increased after 2 d (2.80 ± 
0.17-fold, 2.58 ± 0.16-fold, 3.68 ± 0.33-fold) and 10 d (3.11 ± 0.12-fold, 1.71 ± 0.14-fold, 
3.66 ± 0.29-fold) pretreatment with 30 μM ICAR. PECAM-1 expression was increased only 
after 2 d (2.56 ± 0.06-fold, P < 0.01) cultivation, but reduced after 10 d treatment (0.42 ± 
0.05-fold, P < 0.01). VE-cadherin expression was downregulated by 98.7% after 2 d and by 
99.0% after 10 d with a similar trend for bFGF expression. But vWF gene expression was 
not affected by ICAR treatment (Figure 13C).  
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Figure 13. Gene expression analysis of SAL, SalB and ICAR-treated BM-EPCs. BM-EPCs were 
cultivated in endothelial basal medium with or without 80 μM SAL (A), 20 μM (B), 30 μM ICAR (C) for 
2 and 10 d. Gene expression levels of VEGF, KDR, eNOS, VE-cadherin, vWF and PECAM-1 were 
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assessed via quantitative RT-PCR. Data were normalized to GAPDH expression and fold changes were 
calculated by the 2
−ΔΔCT
 method, n=5, 
＊
P < 0.05, 
＊＊
P < 0.01 versus control group. 
 
3.1.8 SAL and ICAR induce angiogenic differentiation via Akt/mTOR/p70S6K 
signaling pathways 
Evaluating key pathway components involved in cellular function and angiogenesis we 
found that SAL effectively triggered the phosphorylation of mTOR signaling cascade, 
including Akt, mTOR, and p70S6K (Ser371) in BM-EPCs in a concentration-dependent 
manner (Figure 14A). Furthermore, we used the highly specific PI3-K inhibitor LY294002 
to assess the role of the PI3-K/Akt pathway in angiogenesis. Unexpectedly, LY294002 
inhibited not only Akt, but also notably phosphorylated mTOR (Figure 14B). Cell migration 
and tube formation ability were significantly decreased when SAL was co-administered 
with LY294002 (Figure 14D, 14E), suggesting that SAL promotes cell mobility and 
angiogenesis through activating the Akt/mTOR signaling pathway. To further define the 
roles of MAPK in the SAL-induced effects on BM-EPCs, we analyzed the expression of 
phosphorylated ERK1/2, p38 MAPK, and JNK following SAL treatment. As demonstrated 
in Figure 14A, the phosphorylation levels of ERK1/2 were increased after SAL treatment 
for 48 h. However, no significant changes of phosphorylation levels of p38 MAPK and JNK 
were observed after SAL treatment. Additionally, application of ERK 1/2 inhibitor U0126 
also markedly reduced the phosphorylated expression of mTOR (Figure 14C) and blocked 
SAL-induced cell migration as well as angiogenesis (Figure 14D, 14E). This implies that, 
by interaction with mTOR, ERK1/2 is a potential target of SAL in BM-EPCs.  
As shown in Figure 14F, treatment with ICAR (30 μM) alone significantly increased 
the expression of p-mTOR, p-p70S6K, and p-4EBP1 within 48 h. The phosphorylation of 
mTOR, p70S6K and 4EBP1 by ICAR was prevented with application of LY294002 (20 μM) 
(Figure 14G), illustrating again that phosphorylation of mTOR/p70S6K/4EBP1 was 
dependent upon activation of the PI 3-K pathway. Moreover, the promotion effect of ICAR 
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on migration and capillary tube formation ability were suppressed by rapamycin (Figure 
14H, 14I), which imply a possible role of mTOR in the cell motility and angiogenesis ability. 
To further demonstrate the downstream protein that may regulate the effect of ICAR, we 
used specific siRNA to silence the 4EBP1 gene expression in EPCs. qRT-PCR and Western 
blot analysis were performed to ensure the adequate knocking down of 4EBP1 (Figure 14J). 
We observed that the tube formation induced by ICAR was suppressed markedly when 
4EBP1 was silenced (Figure 14K). Interestingly, when 4EBP1 is downregulated, rapamycin 
inhibition of both basal and ICAR-stimulated cell motility was dramatically attenuated 
(Figure 14L).     
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Figure 14. Signal pathway analysis of SAL and ICAR-treated BM-EPCs. (A, F) BM-EPCs were treated 
with or without TCM extracts for 48 h and then harvested. Total cell lysates were prepared and subjected 
to sodium dodecyl sulfate polyacrylamide gel electrophoresis, followed by Western blot analysis. The 
immunoblots shown are representative of at least three independent experiments with comparable results. 
(B, C, G) BM-EPCs were pretreated with 20 µM LY294002 or 10 µM U0126 for 90 min, then cultured 
with SAL or ICAR for 48 h. Protein expression was analyzed by Western blot analysis. (D, E, H, I) 
BM-EPCs were treated under the same conditions described above, cell migratory ability and 
capillary-like tube formation were determined by the methods as above, n=3. (J) BM-EPCs were 
transfected with 4EBP1-specific or non-specific siRNA. 48 h after transfection, mRNA and protein 
expression were measured to determine the efficiency of the silence. (K, L) BM-EPCs were incubated in 
the absence or presence of 4EBP1 siRNA for 48 h, then treated with rapamycin for 90 min, and 
stimulated by ICAR for 48 h, capillary-like tube formation and cell migration ability were determined by 
the methods as above, n=4. All data are presented as mean ± SD. 
＊
P < 0.05, 
＊＊
P < 0.01. 
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3.1.9 SAL augments bone healing in vivo 
Therapeutic benefit of growth factor and SAL in vivo by embedding into the 
mineralized collagen scaffold were tested in femoral critical-size bone defect of 
immunodeficient mice. As shown in Figure 15E-G, after 6 weeks, the therapy with BMP-2 
or SAL both resulted in an significant augment in total bone growth compared to the control 
group as corroborated by micro-CT.  
 
Figure 15. SAL augments bone healing in vivo. (A) Representative picture of the mineralized collagen 
scaffolds. (B-D) The external fixator that was used in the animal study and the murine defect model. (E, 
F, G) Representative μCT images of a murine bone defect after 6 weeks, that was treated with 
mineralized collagen scaffolds functionalized with SAL or BMP-2. In animals treated with 
SAL-functionalized implants, improved bone formation was observed (images kindly provided by Dr. 
Stefan Zwingenberger, Stiehler group). 
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3.2  TCM extracts prevent oxidative stress-mediated dysfunction in bone marrow 
derived-endothelial progenitor cell 
 
3.2.1 SAL, SalB and ICAR inhibit cell death induced by H2O2 
Although TCM extracts significantly enhanced the cell function in vitro, we wanted to 
investigate whether TCM extracts protect cell cultures from H2O2-induced apoptosis. To 
assess the consequences of TCM extracts treatment on the apoptotic effect induced by H2O2, 
BM-EPCs were double-stained with calcein-AM/EthD-1. While in the absence of H2O2 
nearly all cells were alive, the addition of 1 mM H2O2 induced a significant level of 
apoptosis, as showed by contraction and nuclear membrane creasing. In contrast, very few 
cells preincubated with SAL, SalB or ICAR were EthD-1-positive. Cell retained good 
morphology without cytoplasm injury (Figure 16A), indicating a protective effect of SAL 
from H2O2 induced cell death. 
As shown in Figure 16B, 48 h preincubation with 40 and 80 μM SAL 
dose-dependently attenuated the H2O2-induced cell death by 14.7% and 25.0%, respectively. 
Notably, cell death was also remarkably attenuated by 28.4% and 36.8% when pretreated 
with 10 μM and 20 μM SalB, respectively. And the pretreatment with ICAR at 15 and 
30 μM reduced the cell death by 38.3% and 42.4%, respectively. 
Furthermore, LDH levels in the cell culture supernatant significantly increased after 
exposure to 1 mM H2O2 (Figure 16C, 42.0 ± 1.5%, P < 0.01). The considerable adverse 
effect of H2O2 was significantly attenuated by pretreatment of BM-EPCs with 80 μM SAL 
(29.9 ± 1.1%), 10 μM (21.9 ± 1.3%) and 20 μM (19.4 ± 0.6) SalB, as well as 15 μM (28.4 ± 
1.4%) and 30 μM (19.5% ± 2.1%) ICAR, but not in the control group. These results 
demonstrated that TCM extracts can obviously protect BM-EPCs against H2O2-induced cell 
damage (Figure 16C).  
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Figure 16. SAL, SalB and ICAR protect BM-EPCs from H2O2-induced cell damage. (A) Cells were 
pretreated with indicated concentrations of TCM extracts and stressed by 1 mM H2O2. Cell survival was 
monitored by calcein AM/EthD-1 double staining and analyzed qualitatively by fluorescence microscopy. 
Representative micrographs from each treatment group are shown. (B) After the treatment with TCM 
extracts and induction by 1 mM H2O2, BM-EPCs were washed with PBS and cellular viability was 
evaluated by quantification of DNA content, n=6. (C) Cell death was evaluated by LDH assay, n=4. All 
data are expressed as mean ± SD. 
＊
P < 0.05, 
＊＊
P < 0.01 versus H2O2 group. 
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3.2.2 SAL and SalB suppress H2O2-induced production of ROS and NADPH 
expression 
As shown in Figure 17A and 17B, when compared with BM-EPCs incubated in 
EBM-2 alone, the addition of SAL to the cells did not affect the amount of ROS produced 
(104.8% ± 10.0% at 40 μM SAL and 97.5% ± 4.1% at 80 μM SAL, respectively). However, 
after exposure to 1 mM H2O2 for 6 h, fluorescence from the cells stained with DCFDA 
indicated that intracellular ROS had accumulated significantly in BM-EPCs (368.8% ± 8.3% 
control w/ H2O2 vs. control w/o H2O2), but pretreatment with SAL annihilated ROS 
production to nearly normal levels (160.2% ± 14.7% at 40 μM SAL and 147.3% ± 12.8% at 
80 μM SAL, respectively).  
The multimeric enzyme complex NADPH oxidase (Nox) is the major enzyme system 
generating superoxide in the vasculature. H2O2 markedly stimulatated NADPH oxidase 
activity suggesting that NADPH oxidase is an important source of H2O2-induced oxidative 
stress in BM-EPCs. Pretreatment with SAL (40 μM and 80 μM) significantly decreased 
H2O2-induced NADPH production by 23.1% ± 2.3% and 29.4% ± 1.0% respectively (Figure 
17C). Hence SAL has a potent antioxidant activity on H2O2-induced ROS production and 
this may be mediated partly through inhibition of NADPH oxidase activity. To highlight the 
role of NADPH, diphenyliodonium (DPI) as an NADPH oxidase inhibitor was added to the 
cells for 90 min before H2O2 stimulation. DPI (10 μM) treatment significantly attenuated 
H2O2-induced generation of ROS and damage on cellular viability, and showed an enhanced 
effect when combined with 80 μM SAL (Figure 17D, 17E). 
As shown in Figure 17F, 48 pretreatment with SalB (10 μM and 20 μM) also 
annihilated ROS production to nearly physiological levels (146.8% ± 5.9% and 109.1% ± 
9.0% for 10 and 20 μM SalB, respectively) and decreased H2O2-induced NADPH 
production by 13.7% ± 1.2% and 37.0% ± 1.4%, respectively (Figure 17H). Additionally, 
compared to cells treated with H2O2, also NO generation was restored by SalB to a 
physiological level (Figure 17I). In an effort to confirm the protective effect of SalB 
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qRT-PCR revealed that mRNA expression levels of both both Nox4 and eNOS were 
considerably decreased by SalB (P < 0.01) (Figure 17J, 17K). Interestingly, treatment of 
BM-EPCs with 10 μM eNOS inhibitor L-NAME significantly prevented cell damage as 
demonstrated by decreased ROS generation (64.6% of H2O2 group, P < 0.01) and DHE level 
(74.0% of H2O2 group, P < 0.05) (Figure 17L, 17M), and enhanced the inhibitory effect of 
SalB. This finding indicates that the protective effect of SalB was at least partially 
dependent on the cells’ ability to downregulate eNOS.  
In order to evaluate the role of NADPH in this context, the NADPH oxidase inhibitor 
diphenyleneiodonium (DPI) was added prior to H2O2 stimulation. As shown in Figure 17N, 
17O, DPI (10 μM) treatment significantly attenuated H2O2-induced Nox4 and eNOS 
expression, and undermined the suppressive effect exerted by SalB.  
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Figure 17. SAL and SalB suppress H2O2-induced production of ROS and NADPH expression. (A, F) 
Cells were pretreated with 40 and 80 µM SAL, or 10 and 20 µM SalB for 48 h, labeled with 30 µM 
DCFH-DA and subsequently stressed with H2O2 for 6 h prior to fluorescence microscopy. (B, G) 
Production of ROS was quantified by the amount of DCF formed in the BM-EPCs. The fluorescence 
intensity was measured using a microplate reader, n=6. (C, H) Cells were treated with 40 and 80 µM SAL, 
or 10 and 20 µM SalB for 48 h, followed by H2O2 treatment for 6 h. NADPH oxidase activity was 
measured colorimetrically using NADP/NADPH assay kit, n=5. (D, E) Cells were treated with 40 and 80 
µM SAL for 48 h, and then stimulated with H2O2 for 6 h with pretreatment of 10 µM DPI. ROS was 
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quantified by DCF formation as described above (n=4), and cellular viability was evaluated by 
quantification of DNA content (n=3). (I) Cells were treated with 10 and 20 µM SalB for 48 h, and then 
stimulated with H2O2 for 6 h. Cell culture supernatants were collected and analyzed by Griess assay, n=4. 
(J, K) qRT-PCR was performed to measure Nox4 and eNOS mRNA expression levels in BM-EPCs in 
response to H2O2 stimulation with or without pretreatment by SalB over 48 h, n=4. (L, M) BM-EPCs 
were pretreated with SalB for 48 h, then incubated with 10 μM L-NAME for 90 min followed by 1 mM 
H2O2 for 6 h, ROS production and DHE level were assessed by fluorescence quantification, n=3. 
BM-EPCs were treated with 1 mM H2O2 in the absence or presence of 10 μM NOS inhibitor L-NAME, 
ROS production and mRNA level of Nox4 were assessed by DCF quantification (n=3) and by qRT-PCR, 
n=4. (N, O) BM-EPCs were pretreated with SalB for 48 h, then incubated with 10 μM DPI for 60 min 
followed by 1 mM H2O2 for 6 h, Nox4 and eNOS mRNA expression was quantified by qRT-PCR, n=4. 
All data are expressed as mean ± SD, 
＊
P < 0.05, 
＊＊
P < 0.01 versus H2O2 group.   
 
3.2.3 SAL, SalB and ICAR protect mitochondrial function and inhibit 
mitochondrion-induced apoptosis 
Furthermore, the mitochondrial function of the BM-EPCs was monitored using the 
fluorescent dye Rhodamine 123. After incubation with H2O2 for 6 h, the mean fluorescence 
intensity of Rhodamine 123 decreased to 65.5% compared to control cells, respectively 
(Figure 18A, 18B), representing a loss of MMP and a special oxidation of mitochondria. 
SAL (40 and 80 μM), SalB (10 and 20 μM), ICAR (15 and 30 μM) all alleviated 
mitochondrial injury remarkably, which restored the potential to nearly normal levels 
(Figure 18B). Moreover, the cells exposed to H2O2 exhibited enhanced DHE fluorescence 
when compared with control cells (Figure 18C). But the increase in DHE fluorescence in 
response to H2O2 was remarkably prevented by co-administration of SAL, SalB or ICAR 
(Figure 18A, 18C), which implied a suppression effect of superoxide radicals production 
imposed by TCM extracts. Furthermore, the method of Annexin V-FITC and PI double 
staining was employed to investigate the effect of SAL on H2O2-induced apoptosis. As 
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shown in Figure 18D, the apoptosis and necrosis rate were decreased significantly after cells 
were treated with both 40 and 80 μM SAL for 48 h.  
Bcl-xL and Bax expression levels were detected to assess mitochondrial related 
apoptosis. The immunofluorescence data showed significantly increased Bax levels upon 
H2O2 stimulation and markedly attenuated levels of the apoptosis marker after 48 h SalB (10 
and 20 µM) pretreatment (Figure 18E). On the other hand Bcl-xL expression was declined 
in H2O2-stressed BM-EPCs and restored in the presence of 10 and 20 µM SalB (Figure 18F). 
Immunoblot analysis supported this finding demonstrating that SalB reversed both 
H2O2-induced increased Bax/Bcl-xL ratio and oxidative stress activated cleaved PARP, 
cleaved caspase-3 protein expression, as well as cytochrome c release (Figure 18F). These 
findings suggest that SalB counteracts mitochondria-mediated apoptosis by modulating 
Bcl-2 family proteins. 
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Figure 18. SAL, SalB and ICAR inhibit H2O2-induced cell apoptosis. BM-EPCs were pretreated with 
indicated concentrations of TCM extracts for 48 h and stressed by 1 mM H2O2. (A) Then cells were 
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labeled with the fluorescent dye Rhodamine 123, the superoxide indicator DHE and the nucleic acid stain 
Hoechst 33258, n=4. (B) BM-EPCs were loaded with 5 µM Rhodamine 123. After 20 min incubation in 
the dark, cells were washed twice with phosphate buffered saline, and the plates were immediately read 
using a fluorescent plate reader, n=5. (C) Cells were probed with 10 µM DHE for 30 min, fluorescence 
intensity was acquired using a fluorescent plate reader, n=4. (D) Cells were harvested and labeled with a 
combination of annexin V-FITC and PI. H2O2-induced apoptosis was determined by flow cytometry, n=3. 
(E)  Immunofluorescence. Bcl-xL and Bax were stained with primary antibodies followed by staining 
with secondary Cy3-conjugated antibody. Cell nuclei were labeled with DAPI and immunofluorescence 
analysis was performed under the fluorescence microscope. (F) Relative changes in cytochrome c, PARP, 
cleaved caspase-3, Bax and Bcl-xL protein levels were analyzed by Western blot. GAPDH was used as a 
loading control. All data are expressed as mean ± SD, 
＊
P < 0.05, 
＊＊
P < 0.01 versus H2O2 group. 
 
3.2.4 SAL protects BM-EPCs from H2O2-induced injury through JNK, p38 MAPK 
pathways and modulates the levels of Bcl-2 family proteins 
In order to investigate the mechanisms underlying SALs protective effect towards 
oxidative stress, the expression of Nox4, STAT-3 as well as some endothelial genes was 
investigated. The results showed that Nox4 as well as STAT-3 expression was decreased 
considerably (Figure 19A). Compared to cells treated with H2O2, gene expression of VEGF 
of SAL-stimulated cells was increased to nearly the same level found in H2O2-untreated 
cells. BM-EPCs preincubated with SAL and treated with H2O2 also showed an enhanced 
KDR expression. Compared to untreated cells, H2O2-stimulated cells showed a significantly 
higher eNOS expression. However, pretreatment with SAL for 48 h attenuated this increase 
to a normal level (Figure 19A).  
Since Bcl-2 family proteins play important roles in apoptosis by functioning as 
promoters or inhibitors of cell death processes, we next studied the changes in the levels of 
Bax/Bcl-xL in BM-EPCs after exposing to H2O2. Western blot analysis showed that 1 mM 
H2O2 caused a profound up-regulation of pro-apoptotic protein Bax and downregulation of 
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Bcl-xL, which strongly increased the ratio of Bax/Bcl-xL. But SAL preincubation reversed 
this high ratio of Bax/Bcl-xL notably by declining Bax and restoring Bcl-xL expression 
(Figure 19B). To further elucidate the underlying mechanisms of the protective effect of 
SAL, phosphorylation of JNK, p38 MAPK and ERK1/2 were determined. As shown in 
Figure 19B, stimulation of BM-EPCs with H2O2 induced the phosphorylation of all the three 
targets, whereas SAL pretreatment significantly inhibited the upregulation of both 
phosphorylated JNK and p38 MAPK, but not ERK1/2.  
 
Figure 19. Gene expression and signal pathway analysis of SAL-treated BM-EPCs upon oxidative stress. 
(A) BM-EPCs were treated with 80 µM SAL for 2 d, then incubated with 1 mM H2O2 for 6 h and gene 
expression levels of Nox4, STAT3, VEGF, KDR, eNOS were determined, n=3. (B) Cells were incubated 
without or with 80 μM SAL for 48 h before stimulation with 1 mM H2O2. Total protein (30 μg) was 
isolated from the cells, applied to Western blot and probed with specific antibodies. The immunoblots 
shown here are representative of at least three independent experiments with similar results. All data are 
presented as mean ± SD. 
＊
P < 0.05, 
＊＊
P < 0.01 versus H2O2 group. 
 
3.2.5 SalB exerts its cytoprotective potential via mTOR signaling pathway 
Cellular proliferation and survival require the involvement of mTOR and 
phosphoinositide 3-kinase (PI3-K)/Akt pathways (Sato et al., 2010). Since SalB employs 
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mTOR to modulate the phosphorylation of p70S6K and 4EBP1, we assessed whether the 
cytoprotective effects SalB also involves the Akt/mTOR pathway. BM-EPCs were stressed 
by 1 mM H2O2 for 6 h prior to protein extraction and Western blot analysis. As shown in 
Figure 20A, H2O2 induction almost blocked the expression of p-mTOR, as well as 
p-p70S6K and p-4EBP1, while SalB (20 μM) significantly restored the expression of these 
proteins in the presence of H2O2. We hypothesized that mTOR/p70S6K/4EBP1 activation is 
responsible for the observed increased cell survival in response to H2O2 and thus performed 
inhibiting experiments by use of rapamycin. As shown in Figure 20B, rapamycin 
completely reversed SalB-mediated mTOR/p70S6K/4EBP1 phosphorylation in response to 
H2O2. Furthermore, increased expression of p-mTOR, p-p70S6K and p-4EBP1 by SalB 
during H2O2 exposure was blocked during application of the PI3-K inhibitor LY294002 (20 
μM) (Figure 20C). In addition, a considerable decrease in cell survival rate was found when 
rapamycin (73.9% of SalB+H2O2 group, P < 0.01) or LY294002 (77.1% of SalB+H2O2 
group, P < 0.01) were applied combined with SalB (Figure 20D). These results 
demonstrated that SalB exerted its cytoprotective potential via mTOR signaling pathway.  
To further demonstrate the downstream protein that may regulate the effect of SalB, we 
used specific siRNA to silence the 4EBP1 expression in BM-EPCs. RT-PCR and Western 
blot analyses were performed to ensure adequate knocking down of 4EBP1 (Figure 20E). 
Consequently, cleaved caspase-3 and Bax induction by H2O2 were enhanced in 4EBP1 
siRNA-transfected cells, whereas the Bcl-xL expression was declined (Figure 20F, 20G). 
More importantly, cell viability was significantly decreased while ROS production was 
considerably elevated during inhibition of 4EBP1, suggesting that the protection by SalB is 
significantly reduced in case of 4EBP1 knockdown (Figure 20H, 20I). Taken together, these 
observations demonstrate that the cytoprotective, antioxidative properties of SalB rely upon 
mTOR/4EBP1 to offer cellular protection during oxidant stress. Unexpectedly, both 
rapamycin treatment 4EBP1 and 4EBP1 knockdown activated phosphorylated p38 level, but 
did not facilitate the induced effect of H2O2 on p-ERK1/2 (Figure 20J, 20K). We 
hypothesize that oxidative stress induced activation of p38 MAPK suppresses the 
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physiological mTOR/4EBP1 activity of proliferating and differentiating cells and, in turn, 
this loss of mTOR activity sensitizes the BM-EPCs to p38 mediated apoptosis. 
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Figure 20. SalB provides cellular protection against oxidative stress in BM-EPCs through mTOR and its 
signaling pathways. (A) Cells were pretreated with 20 µM SalB for 48 h, and incubated with H2O2 for 6 h, 
Western blot analysis was used for determination of p-mTOR, p-p70S6K and p-4EBP1 levels. (B, C) 
SalB (20 µM) alone or combined with rapamycin (100 nM) or LY294002 (20 μM) were applied to 
BM-EPCs prior to H2O2 treatment, and Western blot analysis was performed. (D) in the presence of 
rapamycin or LY294002 in response to H2O2-stimulation for 6 h, Cellular survival rates were determined 
by quantification of DNA content, n=5. (E) BM-EPCs were transfected with 4EBP1-specific or 
non-specific siRNA. 48 h after transfection, mRNA and protein expression were measured to determine 
the efficiency of the silence. (F, G) BM-EPCs were incubated in the absence or presence of 4EBP1 
siRNA for 48 h, then cells were treated by SalB and H2O2
-
stimulation, and indicated protein expressions 
were measured by Western blot. (H, I) Cellular viability and ROS generation were determined by 
quantification of DNA content (n=5) and by the amount of DCF formed (n=5) in cells in the presence or 
absence of 4EBP1 siRNA, in response to either SalB treatment or H2O2-stimulation. (J, K) p-p38 MAPK 
and p-ERK1/2 protein expression levels were detected in the presence of rapamycin or 4EBP1 siRNA in 
response to H2O2
 
stimulation for 6 h. The densitometric analysis of all Western blot band intensities were 
normalized to the total proteins or GAPDH. All data are expressed as mean ± SD, 
＊
P < 0.05, 
＊＊
P < 0.01. 
ns, not significant.  
 
3.2.6 SalB inhibits activation of H2O2-induced MKK3/6-p38 MAPK-ATF2 pathways in 
BM-EPCs 
MAPK signaling pathway is considered crucial for intracellular signal transduction 
events upon oxidative stress. In our study, H2O2 loading was associated with an increase in 
the phosphorylation of p38 MAPK, which was significantly inhibited by SalB pretreatment 
(Figure 21A). In considering the impact of SalB on signaling events both upstream and 
downstream of p38 MAPK, we assessed oxidative-dependent phosphorylation of the 
upstream kinase MKK3/6 and of the downstream effector ATF2. Notably, the markedly 
increased levels of MKK3/6 and ATF2 mediated by oxidative stress were suppressed by 
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SalB (Figure 21A). In contrast to upstream MKK-mediated p38 MAPK phosphorylation, 
autophosphorylation requires p38 MAPK intrinsic kinase activity. We therefore examined 
whether inhibition of p38 MAPK activity by SB203580 abolishes p38 MAPK 
phosphorylation induced by H2O2. As shown in Figure 21B, the enhancement of p38 MAPK 
phosphorylation by H2O2 treatment was significantly attenuated by the presence of 
SB203580 (10 μM). However, the baseline level of p38 phosphorylation was not changed 
by SB203580 suggesting that constitutive activation of MKK3/6 contributes to the baseline 
level of p38 MAPK activation that is independent of H2O2-triggered p38 MAPK 
phosphorylation. Furthermore, immunoblot analysis showed that the increase in caspase-3 
activation and Bax/Bcl-xL ratio were prevented by treatment with SB203580 (Figure 21B). 
The presence of SB203580 significantly abolished the protective effect imposed by SalB, as 
observed in cell viability and ROS generation assays (Figure 21C, 21D). No influence of 
SB203580 on the expression levels of p-ERK1/2 or total ERK1/2 and p-JNK or total JNK 
was detected (data not shown). To further confirm the results derived from the cytotoxicity 
assay, we examined the protein levels of both cleaved caspase-3 and Bax/Bcl-xL in 
BM-EPCs and found that the inhibition of p38 significantly suppressed the induction of 
cleaved caspase-3 protein levels in BM-EPCs upon H2O2 treatment (Figure 21B). Strikingly, 
inhibition of p38 MAPK by SB203580 completely abolished the prevention by SalB on 
cleaved caspase-3 and Bax/Bcl-xL expression suggesting that inactivation of p38 MAPK 
pathway plays a critical role in SalB mediated protection against H2O2-induced oxidative 
stress in BM-EPCs.  
    To determine the role of ATF2 in the context of SalB-mediated cytoprotective effects, 
mRNA expression was determined by qRT-PCR. As shown in Figure 21E, the increase in 
ATF2 expression was prevented by treatment with SB203580. And the presence of 
SB203580 or U0126 all significantly suppressed ATF2 level induced by H2O2. After ATF2 
was knocked down by siRNA, RT-PCR and Western blot analyses were performed to 
ensure adequate silencing (Figure 21F). ATF2 knockdown modestly decreased 
H2O2-stimulated phosphorylation of p38 MAPK compared with cells transfected with the 
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non-specific siRNA. H2O2-caused cleavage of caspase-3 and increased Bax/Bcl-xL ratio 
expression were largely inhibited when cells were silenced with ATF2 (Figure 21G, 21H). 
In addition, knockdown of ATF2 suppressed ROS production (53.5% of non-silenced H2O2 
group, P < 0.01) and promoted cell survival (1.66-fold of non-silenced H2O2 group, P < 0.01) 
upon H2O2-induced oxidative stress in BM-EPCs (Figure 21I, 21J), illustrating that loss of 
ATF2 is protective during H2O2 exposure. 
In summary, the combined data support a model in which oxidation triggers p38 
activation, potentially via MKK3/6, which in turn induces the proapoptotic ATF2. Our data 
indicate that MKK3/6-p38 MAPK-ATF2 signaling are the principal target pathways of 
SalB. 
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Figure 21. SalB inhibits H2O2-induced MKK3/6-p38 MAPK-ATF2 pathways in BM-EPCs. (A) 
BM-EPCs were treated with or without 20 μM SalB, then stimulated by 1 mM H2O2, MKK3/6, p38 
MAPK, ATF2 were detected with phospho-specific antibodies by Western blot. (B) Forty-eight hours 
after SalB treatment BM-EPCs were further incubated with selective p38 MAPK inhibitor SB203580 
(10 μM) and 1 mM H2O2, and protein expression was assessed by Western blot analysis. (C, D, E) 
Cellular viability, ROS generation and mRNA level of ATF2 were determined by quantification of DNA 
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content (n = 5), by the amount of cellular DCF synthesis (n=3), and by qRT-PCR (n=3) in the presence of 
SalB or SB203580 in response to H2O2
-
stimulation for 6 h. (F) BM-EPCs were transfected with 
ATF2-specific or non-specific siRNA. 48 h after transfection, mRNA and protein expression were 
measured to determine the efficiency of the silence. (G, H) BM-EPCs were incubated in the absence or 
presence of ATF2 siRNA for 48 h, then cells were treated by SalB and H2O2-stimulation, and protein 
expression was measured by Western blot. (I, J) Cellular viability and ROS generation were determined 
by quantification of DNA content and by the amount of cellular DCF formation in the presence or 
absence of ATF2 siRNA, in response to either SalB treatment or H2O2-stimulation, n=4. The 
densitometric analysis of all Western blot band intensities were normalized to the total proteins or 
GAPDH. All data are shown as mean ± SD. 
＊
P < 0.05, 
＊＊
P < 0.01. ns, not significant. 
 
3.2,7 Inhibition of ERK1/2 by SalB prevents H2O2- mediated injury in BM-EPCs 
ROS is known to be related with p38 MAPK (Jiang et al., 2011). In order to confirm 
that SalB inhibits H2O2-induced p38 MAPK phosphorylation via decreased ROS generation, 
DPI was added prior to H2O2 stimulation. As shown in Figure 22A, 22B, DPI treatment 
significantly attenuated H2O2-induced generation of ROS and cell death in BM-EPCs. 
Notably this effect was enhanced by 20 μM SalB. DPI partially inhibited phosphorylation of 
p38 MAPK during H2O2 stress and enhanced the inhibitory effect of SalB on p-p38 MAPK 
and p-ATF2 (Figure 22C, 22D). Furthermore, DPI strongly suppressed the H2O2-stimulated 
cleaved caspase-3 and Bax/Bcl-xL ratio, and enhanced the aforementioned suppressive 
effect of SalB on these proteins (Figure 22C, 22D). In summary, these findings suggest a 
positive feedback loop involving NADPH oxidase, H2O2, and p38 MAPK amplifying the 
signaling pathways related to oxidative stress-induced cell injury in BM-EPCs that can be 
modulated by SalB. 
The ERK1/2 pathway is associated with protection against apoptosis. In our study, 
pretreatment with 20 μM SalB for 48 h prior to H2O2 exposure inhibited the H2O2-induced 
ERK1/2 activation, while total ERK1/2 expression was not altered in any treatment group 
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(Figure 22E). The NADPH oxidase inhibitor DPI treatment also showed an inhibition on 
H2O2-induced ERK1/2 phosphorylation (Figure 22F). To evaluate the putative role of 
ERK1/2 pathways on H2O2-induced apoptosis in the presence of SalB, cells were 
preincubated for 60 min with the selective MEK1 and MEK2 inhibitor U0126 (10 μM) prior 
to H2O2 (1 mM) addition. U0126 markedly reduced the phosphorylation of ERK1/2 and the 
abundance of Bax/Bcl-xL ratio, and enhanced the anti-apoptotic effect of SalB on 
H2O2-induced cell dysfunction in BM-EPCs (Figure 22F). In addition, phosphor-ATF2 
stimulated by H2O2 was downregulated by U0126 (Figure 22F). Furthermore, inhibition of 
ERK1/2 by U0126 markedly prevented ROS production (60.7% of H2O2 group) and 
counteracted cell damage (1.45-fold of H2O2 group) imposed by H2O2, which showed an 
additive effect when combined with 20 μM SalB (Figure 22G, 22H). These data highlight 
the blockade of ERK1/2 by SalB plays a critical role in counteracting H2O2-induced 
oxidative stress and EPCs dysfunction.  
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Figure 22. Inhibition of ERK1/2 by SalB prevents H2O2- mediated injury in BM-EPCs. (A, B) 
Forty-eight hours after SalB treatment, BM-EPCs were further incubated with 1 mM H2O2 alone or in 
combination with 10 μM of DPI, cellular viability and ROS generation were determined by quantification 
of DNA content and by the amount of cellular DCF formation, n=6. (C, D) Indicated protein expressions 
were detected by Western blot in the presence or absence of DPI, in response to SalB treatment (or not) 
and H2O2-stimulation. (E) Cells were pretreated with 20 µM SalB for 48 h, and incubated with H2O2 for 6 
h, protein expression of p-ERK1/2 and total ERK1/2 were determined by Western blot. (F) Forty-eight 
hours after SalB treatment, BM-EPCs were further incubated with 1 mM H2O2 alone or in combination 
with 10 μM of DPI or 10 μM of U0126, and Western blot was performed to detect protein expression. (G, 
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H) ROS generation and cellular viability were determined by the amount of cellular DCF formation and 
quantification of DNA content in the presence of either SalB or U0126 in response to H2O2-stimulation 
for 6 h, n=4. Data are expressed as mean ± SD, 
＊
P < 0.05, 
＊＊
P < 0.01. 
 
3.2.8 ICAR restores loss of mTOR phosphorylation induced by H2O2, which is 
associated with autophagy inhibition  
Since ICAR employs mTOR to modulate cell angiogenic differentiation as described 
above, we assessed whether ICAR also relies upon the PI 3-K/Akt/mTOR pathway to 
protect cells. As showed in Figure 23A, H2O2 (1 mM) markedly decreased p-mTOR, 
p-p70S6K, as well as p-4EBP1 expression in BM-EPCs. Conversely, ICAR pretreatment 
restored p-mTOR protein expression and its two targets, p70S6K and 4EBP1 back to nearly 
baseline levels. We considered the possibility that the higher mTOR/p70S6K/4EBP1 
activation in cells could be responsible for the increased survival in response to H2O2. Thus, 
we inhibited this pathway with rapamycin to evaluate it. As shown in Figure 23B -6D, 
treatment with rapamycin partly abolished mTOR/p70S6K/4EBP1 phosphorylation by 
ICAR in response to H2O2, and a considerable decrease in cell survival rate was found when 
rapamycin (73.9% of ICAR+H2O2 group, P < 0.01) was applied combined with ICAR. 
Moreover, ROS generation elevated significantly when mTOR was inhibited. 
Compelling evidence demonstrates that the PI3-K/Akt/mTOR pathway is the major 
regulatory signal of autophagy. Inactivation of mTOR is considered as a key step in 
autophagy activation. We therefore investigated whether H2O2-mediated autophagy is 
occurring via an mTOR mediated pathway in our system. As shown in Figure 23E, 
H2O2-induced autophagic flux was observed at 3 h, and then was sustained at high levels 
during 12 h treatment indicated by increased processing of LC3B-I to LC3B-II. 
Sequestome-1 protein (p62/SQSTM1), which was implicated to directly degrade by 
autophagy, was reduced after 3 h in BM-EPCs in response to H2O2-indueced autophagy. 
However, ICAR pretreatment notably decreased LC3B-II/LC3B-I ratio, while restored 
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expression of p62/SQSTM1. Moreover, Beclin-1 protein expression, an upstream promoter 
of autophagic induced cell death pathways, was also attenuated by ICAR remarkably 
(Figure 23F). he suppression effect on cell autophagy was also evidenced by the decreased 
number of acridine orange-positive cells.  
The canonical mTOR inhibitor rapamycin increased autophagic response of the cells 
under the induction by H2O2, which undermined the suppression effect of ICAR on it 
(Figure 23H). In order to examine whether the suppression of autophagy is related to 
oxidative stress-induced cell death, we pretreated BM-EPCs with autophagic inhibitor 
3-methyladenine (3-MA). As shown in Figure 23I, 3-MA inhibited acridine orange-positive 
vacuole accumulation by H2O2, and H2O2-induced accumulation of LC3BII and decrease of 
p62. What’s more, the ratio expression of Bax/Bcl-xL was significantly declined in the 
presence of 3-MA, and a reduced level of cell death was correlated with the observed 
decreased amount of ROS accumulation, further strengthening the association between 
autophagy, ROS, and cell death (Figure 23J-L). 
 
90 
 
 
Figure 23. ICAR restores loss of mTOR phosphorylation induced by H2O2, which is associated with 
autophagy inhibition. (A) BM-EPCs were treated with or without 30 μM ICAR, then stimulated by 1 mM 
H2O2, mTOR, p70S6K and 4EBP1 were detected with phospho-specific antibodies by Western blot. (B) 
Indicated protein expressions were detected by Western blot in the presence or absence of rapamycin, in 
response to ICAR treatment (or not) and H2O2-stimulation. (C, D) ROS generation and cellular survival 
rates were determined by quantification of DCF formation and DNA content in the presence of 
rapamycin or LY294002 in response to H2O2-stimulation for 6 h, n=5. (E) Cells were treated without or 
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with H2O2 for 3, 6, and 12 h, protein expression were detected by Western blot. (F) Cells were treated 
without or with H2O2 for 6 h, acidic intracellular compartments were visualized by acridine orange 
staining. (G, H) BM-EPCs were treated with or without 30 μM ICAR in the presence of rapamycin in 
response to H2O2-stimulation, protein expression was detected by Western blot. (I, J) BM-EPCs were 
pretreated with 3-MA (5 mM), and stressed by H2O2 for 6 h, acidic intracellular compartments were 
visualized by acridine orange staining using fluorescence microscope and indicated protein expression 
was detected by Western blot. (K, L) BM-EPCs were pretreated with 3-MA (5 mM), and stressed by 
H2O2 for 6 h, ROS generation and cellular survival rates were determined by quantification of DCF 
formation and DNA content, n=4. Data are expressed as mean ± SD, 
＊＊
P < 0.01. 
  
3.2.9 Blockade of p38 MAPK/ATF2 attenuates H2O2 induced cell apoptosis and 
autophagy mediated by ICAR 
It has been reported that an increase in p38 MAPK activation sensitizes cells to 
oxidation-induced apoptosis in several cell types. Consistent with previous reports, 
phospho-38 MAPK was rapidly upregulated in response to H2O2 stimulation in our study, 
but ICAR pretreatment significantly decreased the phospho-38 MAPK expression almost 
back to baseline (Figure 24A). ATF2 has been shown to be the downstream effector of p38, 
mediating its proapoptotic function. As shown in Figure 24A, the level of phospho-ATF2 
was also blunted by ICAR pretreatment upon H2O2 induction. The attenuation of ATF2 by 
ICAR was also confirmed at mRNA levels (Figure 24B). To determine a possible role of 
p38 MAPK/ATF2 mediating cell apoptosis and autophagy upon oxidation, BM-EPCs were 
loaded with H2O2 in the absence or presence of the p38 MAPK inhibitor SB203580. As 
shown in Figure 24B and 24C, SB203580 profoundly abrogated H2O2-triggered mRNA 
level and phosphorylated protein expression of ATF2. The ratio expression of Bax/Bcl-xL 
and the cleavage of caspase-3 stimulated by oxidation were significantly prevented by the 
application of SB203580, suggesting that p38 MAPK activation was responsible for 
H2O2-mediated apoptosis in BM-EPCs. Furthermore, we have observed that SB203580 
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prevented the accumulation of LC3-II and restored the expression of p62/SQSTM1 in 
response to H2O2, suggesting that p38 MAPK is necessary for the activation of autophagy 
by oxidation (Figure 24D). No influence of SB203580 on the expression levels of p-ERK1/2 
or total ERK1/2 and p-JNK or total JNK was detected (data not shown). 
To assess the role of NADPH in the anti-injury effect exerted by 
ICAR, diphenyliodonium (DPI), a NADPH oxidase inhibitor, was added to the cells for 90 
min prior to H2O2 stimulation. Treating cells with DPI effectively blocked the H2O2-induced 
activation of p38 MAPK and ATF2, and enhanced the inhibitory effect of ICAR on both of 
them (Figure 24E). DPI strongly suppressed the H2O2-stimulated cleaved caspase-3 and 
Bax/Bcl-xL ratio, and strengthened the suppression effect by ICAR with above proteins. 
More importantly, preincubation of BM-EPCs with DPI dramatically blocked H2O2-induced 
autophagy (Figure 24E). These results confirm the pro-apoptotic role of p38 MAPK and 
identify its novel effect on autophagy during oxidative stress. 
To further investigate whether oxidative stress-induced activation of ATF2 plays a role in 
H2O2-induced autophagy, ATF2 was knocked down by siRNA transfection. Successful 
transfection was confirmed by RT-PCR and Western blot analysis (Figure 24F). As shown 
in the Figure 24G, ATF2 knockdown dramatically decreased numbers of acridine-orange 
positive cells in response to H2O2, and blunted the effect of ICAR. Moreover, H2O2-caused 
cleavage of PARP and caspase-3 were largely inhibited when cells were silenced with ATF2 
(Figure 24H). Cells with low expression of ATF2 showed a reaccumulation of p62 and 
decrease in LC3B-II compared with cells treated with H2O2 alone (Figure 24H). Moreover, 
the knock down of ATF2 abolished the attenuated effect on Bax/Bcl-xL expression and 
autophagy by ICAR in response to H2O2 (Figure 24I). These findings suggest that p38 
MAPK signaling appears to be upstream of autophagic signaling, and the reduction of ATF2 
expression was an important step in H2O2-induced cell apoptosis that also contributed to 
autophagy suppression. In addition, knockdown of ATF2 suppressed ROS production (53.5% 
of non-silenced H2O2 group, P < 0.01) and promoted cell survival (1.66-fold of non-silenced 
H2O2 group, P < 0.01) upon H2O2-induced oxidative stress in BM-EPCs (Figure 24J, 24K). 
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Figure 24. Blockade of p38 MAPK/ATF2 by ICAR attenuates H2O2 induced cell apoptosis and 
autophagy. (A) BM-EPCs were treated with or without 30 μM ICAR, then stimulated by 1 mM H2O2, 
expression of p38 and ATF2 were detected with phospho-specific antibodies by Western blot. (B) mRNA 
level of ATF2 was detected by qRT-PCR in the presence or absence of SB203580, in response to ICAR 
treatment (or not) and H2O2-stimulation, n=5. (C, D) BM-EPCs were pretreated with or without 30 μM 
ICAR in the presence or absence of SB203580, then stimulated by 1 mM H2O2, protein expression was 
detected by Western blot. (E) Indicated protein expressions were detected by Western blot in the presence 
or absence of DPI, in response to ICAR treatment (or not) and H2O2-stimulation. (F) BM-EPCs were 
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transfected with ATF2-specific or non-specific siRNA. 48 h after transfection, mRNA and protein 
expression were measured to determine the efficiency of the silence. (G) BM-EPCs were incubated in the 
absence or presence of ATF2 siRNA for 48 h, then cells were treated by ICAR and H2O2-stimulation, 
acidic intracellular compartments were visualized by acridine orange staining using 
fluorescence microscope. (H, I) BM-EPCs were incubated in the absence or presence of ATF2 siRNA for 
48 h, then cells were treated by ICAR (or not) and H2O2-stimulation, protein expression was measured by 
Western blot. (J, K) BM-EPCs were incubated in the absence or presence of ATF2 siRNA for 48 h, then 
cells were treated by ICAR and H2O2-stimulation, cellular viability and ROS generation were determined 
by quantification of DNA content and by the amount of cellular DCF formation, n=6. Data are expressed 
as mean ± SD, 
＊＊
P < 0.01.  
 
3.2.10 ERK1/2 and p38 MAPK are required for mTOR phosphorylation in 
H2O2-induced autophagy 
In general ERK is believed to activate mTOR; however mTOR inhibition has been 
associated with increased ERK activity in response to non-starvation stress. Since 
H2O2-induced LC3B-II upregulation was found to be accompanied by an increase in 
ERK1/2 phosphorylation, we sought to investigate the role of ERK1/2 pathway in H2O2 
induced autophagy using the MEK1/2 inhibitor U0126. As shown in Figure 25A, H2O2 
loading was associated with an increase in the phosphorylation of ERK1/2, which was 
significantly inhibited by ICAR pretreatment. Moreover, H2O2-induced autophagic 
responses were attenuated when ERK1/2 activity was suppressed by pharmacologic 
inhibitor U0126, suggesting ERK activation is required for autophagy induced by H2O2 in 
BM-EPCs (Figure 25B). What’s more, H2O2 (1mM) reduced phospho-mTOR protein 
expression, while pretreatment with U0126 partially restored phospho-mTOR expression, 
implying that an ERK-mTOR pathway is at least partially involved in H2O2-mediated 
autophagy. Moreover, the ERK inhibition enhanced the suppressive effect of ICAR on 
autophagic response to H2O2 in BM-EPCs (Figure 25C). 
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Figure 25. The role of ERK1/2 and p38 MAPK in mTOR phosphorylation upon H2O2-induced 
autophagy. (A) Forty-eight hours after ICAR treatment, BM-EPCs were further incubated with 1 mM 
H2O2, protein expression of p-ERK1/2 and total ERK1/2 were determined by western blot. (B, C) 
Indicated protein expressions were detected by Western blot in the presence or absence of U0126, in 
response to ICAR treatment (or not) and H2O2-stimulation.  
 
3.2.11 p38 MAPK activation lies eNOS activation to induce apoptotic and autophagic 
cell death 
The mTOR integrates the input from several upstream pathways by sensing the nutrient 
levels, bioenergetic status, and redox state of the cell. We hypothesized that mTOR 
signaling was involved in the p38 MAPK-mediated induction of autophagy. Therefore we 
examined phosphorylation status of p38 MAPK and mTOR after H2O2 and rapamycin 
treatment. Induction of autophagy by rapamycin significantly increased oxidative 
stress-induced apoptosis evidenced by cleavage of caspase 3 and PARP, and increased 
LC3B-II levels with upregulating p38 MAPK phosphorylation, but this effect was all largely 
reversed by the p38 pathway inhibitor SB203580 (Figure 26A). Thus, we concluded that 
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H2O2 induced autophagy via activation of p38 MAPK, which functions through the 
downstream inhibition of the mTOR signaling pathway.  
Since H2O2 exposure induces the upregulation of eNOS, leading to increased free 
radical NO generation. And ICAR administration could counteract these effects 
significantly as shown in Figure 26B, 26C. Further study found that the inhibition of p38 
MAPK activity by SB203580 also attenuated the NO production and eNOS expression 
induced by H2O2. We reasoned that eNOS may also be involved in H2O2 signaling to induce 
cell injury and autophagy. Therefore, we examined the effect of the eNOS 
inhibitor L-NAME on H2O2-induced autophagy in BM-EPCs. Cells were pretreated for 2 h 
with L-NAME and then exposed to H2O2 for 6 h. As shown in Figure 26D-F, pretreatment 
with 10 μM L-NAME significantly reduced H2O2-mediated ROS accumulation and 
autophagy in BM-EPCs. We postulated that p38 MAPK activation lies eNOS activation to 
induce apoptotic and autophagic cell death. 
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Figure 26. p38 MAPK activation lies eNOS activation to induce apoptotic and autophagic cell death. (A) 
Indicated protein expressions were detected by Western blot in the presence or absence of rapamycin or 
SB203580, in response to H2O2-stimulation. (B, C) BM-EPCs were treated with ICAR or SB203580 prior 
to be stimulated by 1 mM H2O2, cell culture supernatants were collected and analyzed by Griess assay, 
n=3; mRNA level of eNOS was detected by qRT-PCR, n=3. (D-F) BM-EPCs were preincubated in the 
absence or presence of L-NAME for 3 h, then cells were treated by H2O2, ROS generation was quantified 
by the amount of cellular DCF formation (n=4), indicated protein expressions were detected by Western 
blot, and acidic intracellular compartments were visualized by acridine orange staining using 
fluorescence microscopy. Data are expressed as mean ± SD, 
＊
P < 0.05, 
＊＊
P < 0.01.  
 
 
 
98 
 
4. DISCUSSION 
Research using immortalized cells has a number of limitations with respect to a 
complete understanding of biological systems in vivo. Primary cells, however, are valuable 
tools enabling the study of a variety of cellular and biochemical functions under tightly 
controlled experimental conditions. In vitro vascularization is an upcoming strategy to solve 
the problem of insufficient blood supply upon construct implantation. Although recent 
publications show promising results, these studies were generally performed with 
endothelial cell model systems not enabling translational conclusions (Verseijden et al., 
2010; Verseijden et al., 2012). To effectively facilitate bone defects repair with tissue 
engineering and treatment of ischemia disease, there is an urgent need for developing safe 
and cost effective drugs that can substitute or cooperate with growth factors for 
angiogenesis promotion. The evaluation of naturally occurring dietary compounds may 
indicate novel approaches for the bone repair. In the present study, we demonstrate the 
effects of TCM extracts (at a near medical applied dose) on the proliferation and 
differentiation of human BM-EPCs, and the underlying mechanisms. We found that TCM 
extracts acted on human BM-EPCs by promoting cellular proliferation, as well as enhancing 
key functional activities including migration, cell-matrix adhesion and tube formation. 
Moreover, TCM extracts initiated a significant increase in VEGF secretion and NO 
production, and exerted a considerable cytoprotective effect upon oxidative stress. 
    Although the proportional contribution of angiogenesis and vasculogenesis to 
neovascularization of adult tissue remains to be determined, it has been shown, either by 
mobilization of EPCs or by injection of in vitro-cultured hematopoietic stem cells, that 
EPCs improved neovascularization of the hind limb and cardiac function (Kalka et al., 2000; 
Murohara, 2003). However, defining EPC is an ongoing debate in the scientific community. 
Different culturing methods (e.g. using early-adherent or non-adherent mononuclear cells) 
and detection of various combinations of surface antigens (e.g. CD14, CD45, and eNOS) 
were reported for the characterization of EPC. Although different morphological and 
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survival features exist to distinguish between early- and late-outgrowth EPCs, these cell 
classes showed comparable in vivo vasculogenic capacity (Hur et al., 2004). The early EPCs 
contribute to neovasculogenesis mainly by secreting angiogenic cytokines, whereas late 
EPCs enhance neovasculogenesis by providing a sufficient number of endothelial cells 
based on their high proliferation potency. Yoon and colleagues reported that mixed 
transplantation of these two types of cells results in synergistic neovascularization through 
cytokines and matrix metalloproteinases (Yoon et al., 2005). 
In order to characterize the EPCs in the present study, immunofluorescence staining 
and flow cytometry were performed. We observed double-uptake of Dil-ac-LDL and 
FITC-UEA-I after 10 d cultivation accompanied by high expression of VEGFR-2 (79.2%), 
E-selectin (46.4), vWF (35.4%), and relatively low expression of CD133 (3.8%), along with 
negative expression of CD45 (Figure 7). Moreover, the appearance of well-circumscribed 
colonies was monitored daily. We found that endothelial colony cannot be efficiently 
obtained from all donors (colonies were generated from 5 donors of the 8 donors), 
indicating a function of donor age. However, the in vitro tubular formation capacities 
between colony-forming cells and non-colony-forming cells did not differ significantly, 
suggesting colony forming ability is not essentially associated with tube formation capacity 
of the cells in vitro. All cells used in the present study were cultivated with EGM-2 at 
passages 3 to 5 and can be categorized as late-outgrowth EPCs according to the previous 
reports (Kalka et al., 2000; Reinisch et al., 2009).  
Angiogenesis is a complex process requiring multiple sequential steps including 
interplay between cells, soluble factors, and ECM components. Vascular endothelium 
proliferation is the first step in angiogenesis, including processes like migration, 
differentiation, survival and death. Under the conditions used in the present study, ICAR 
and PUER show significantly enhancing effect on cell proliferation, but SAL significantly, 
yet non-dose-dependently, promoted proliferation of BM-EPCs at 20, 40, and 80 µM 
(Figure 8). A possible explanation for this finding may be a saturation of the cell receptors 
involved in cell proliferation by SAL at concentrations exceeding 20 μM. Furthermore the 
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absence of a time-dependent effect of SAL on EPCs proliferation at the early time point of 
24 h cultivation can be explained as follows. Firstly, the effect of SAL on cell proliferation 
is indirect via activation of the secretion of cytokines and may therefore be associated with a 
time delay. Secondly, the cells are metabolically more active and thus more responsive to 
the drug after 48 h adherence to the tissue culture polystyrene plate. Thirdly, as we used 
serum-free medium for the proliferation assay to reduce any potential bias on cellular 
function exerted by growth factors, cells grew slowly and thus the time window for 
observing potential proliferative effects by SAL may have been extended. The lack of an 
observed proliferative effect on EPC by SAL at 96 h can be at least partly explained by a 
reduced drug efficacy over time due to a comparatively short half-life of SAL as known 
from in vivo studies.  
 Homing and incorporation of EPCs to the sites of revascularization probably are 
determined not only by the number of circulating EPCs, but also by the motility of the cells. 
The present study provides evidence that SAL and ICAR not only increases the chemotactic 
response of BM-EPCs but SAL per se can trigger the cells’ innate chemoattractive potency 
(Figure 9). 
VEGF is one of the most potent angiogenic cytokines and promotes proliferation of 
vascular cells. Interestingly, there are several reports describing that VEGF increases 
vascular permeability and endothelial cell survival in quiescent vessels, and the cellular 
responses to these effectors involve disruption of the VE-cadherin-based adherent junction 
(Gavard and Gutkind, 2006; Mura et al., 2006; Wong et al., 2009). In our study, SAL and 
ICAR stimulated EPCs tubule formation (Figure 11) in vitro accompanied by enhanced 
mRNA expression and protein secretion of VEGF (Figure 12, 13). Additionally, the mRNA 
expression of VEGF receptor KDR, eNOS, vWF, and PECAM1 were upregulated by SAL 
and ICAR, which in turn promoted EPCs mobilization and differentiation. 
Cell-cell adhesion ensures tight contacts between neighbouring cells, which is 
necessary for cell segregation, as well as for the morphological and functional 
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differentiation of different tissues. Evidently there are cell-cell recognition systems that 
make cells of the same type preferentially adherent to one another. Several studies have 
shown that cell-cell adhesions inhibit cell migration which finally lead to the inability to 
assemble new capillary blood vessels (Lamalice et al., 2007). Homotypic cell 
adhesion plays an important role in mediating a range of physiological processes such as 
cell survival, migration and invasion. Thus in the present study we selected two populations 
of EPCs to investigate the possible effect of TCM extracts on homotypic cell adhesion. 
Many angiogenic factors can destabilize the organization of intercellular junctions, causing 
endothelial barrier opening (Gavard and Gutkind, 2006). VE-cadherin is a transmembrane 
or membrane-associated glycoprotein that mediates specific cell-cell adhesion in a 
Ca
2 +
-dependent manner (Egami et al., 2005; Montero-Balaguer et al., 2009). VE-cadherin 
knockdown in HUVEC resulted in increased tubule formation indicating that it is loss of 
VE-cadherin that leads to increased angiogenesis (Mavria et al., 2006). In the present study, 
the low expression of VE-cadherin after SAL and ICAR treatment suggests decreased 
cell-cell adhesion that may contribute to the enhanced angiogenic effect exerted by them 
(Figure 10).  
The role of NO as a major regulator of cell migration and angiogenesis is suggested by 
the observation that it is produced by eNOS following its activation downstream of the 
VEGFR-2/PI3-K/Akt-PKB axis in endothelial cells activated by VEGF (Williams et al., 
2000). Endothelial-derived NO is essential in the maintenance of vascular homeostasis 
(Drummond et al., 2000; Matz et al., 2000; Murohara and Asahara, 2002). Our results reveal 
a continuously increasing production of NO over time exerted by SAL and ICAR treatment. 
However, inhibition of NO synthesis by L-NAME considerably attenuated the promotion 
effect of SAL on cell migration and tubular formation, implying that NO essentially 
participates in the angiogenic events (Figure 12). 
mTOR functions as a multichannel processor in a cellular nutrient-sensing network by 
receiving multiple inputs derived from distinct environmental cues and directing different 
outputs to appropriate downstream effectors. Several studies have shown the roles of 
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VEGF/Akt/mTOR in potentiating pro-angiogenesis (Fan et al., 2012) and p70S6K, a direct 
downstream target of the mTORC1 (mTOR, GβL, and raptor) in modulating cell migration 
(Berven et al., 2004; Qiu et al., 2004). Of note, it seems that the primary pathway by which 
most growth factors and cytokines activate mTOR and its downstream targets is the 
PI3-K/Akt (Fingar and Blenis, 2004; Li et al., 1999). MAPK signaling is critical during the 
endothelial differentiation of vascular progenitor cell (Takahashi et al., 2012). In our study, 
treatment with SAL showed a marked increase in the phosphorylation of mTOR, p70S6K, 
and its upstream kinase Akt (Figure 14). Moreover, the phosphorylation level of ERK1/2 
was increased significantly upon SAL stimulation. In further blocking experiments we 
observed that LY294002 and U0126 significantly inhibited phosphorylated Akt/mTOR and 
ERK1/2, and consequently led to a decrease in cell migration and tube formation capacity in 
BM-EPCs. The application of rapamycin also showed a suppressive effect on the 
phosphorylation of Akt/mTOR/4EBP1, and remarkably inhibited the promoting effect of 
ICAR on cell mobility and tube formation (Figure 14). What’s more, the results from 
4EBP1-knockdown cells imply distinct role of 4EBP1 in the cell motility and tube 
formation (Figure 14), could be due to the various subcellular localizations 4EBP1 resides 
in, responding to different upstream signals which would result in distinct outcomes. In 
summary, these data suggest that SAL and ICAR promotes proliferation and differentiation 
of EPCs and enhances their functions via activation of the Akt/mTOR/p70S6K/4EBP1 and 
ERK1/2 pathways. 
The development of a microvasculature and microcirculation is critical for the 
homeostasis and regeneration of living bone, without which, the tissue would simply 
degenerate and die. In our preliminary animal study using immunodeficient mice, we found 
that SAL could significantly augment the total bone growth after 6 weeks in a femoral 
critical-size bone defect model (Figure 15). Further studies, however, are necessary to assess 
the potential TCM extracts on EPCs differentiation into neovessels and their integration 
with the host vasculature.  
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Evidence of in vivo exposure to oxidative stress is observed in several diseases or with 
risk factors associated with enhanced vascular pathologies, e.g. atherosclerosis, 
hypertension, diabetes, and heart failure (Cai and Harrison, 2000; Davi and Falco, 2005; 
Leopold and Loscalzo, 2005). A growing body of evidence suggests that oxidative stress 
due to excessive production of ROS is associated with endothelial dysfunction (Harrison et 
al., 2003). Interestingly, cellular oxidant damage is detected before clinically significant 
vascular disease, which support the concept that increased endogenous oxidant stress 
promotes the development of vasculopathies. Strategies to decrease intracellular ROS levels 
have shown therapeutic potential for patients suffering from cardiovascular and metabolic 
disorders and related complications (Li et al., 2009; Virdis et al., 2004). Usually the 
imbalance caused by oxidative stress is derived either from an increase in ROS production 
or from a decreased level of ROS scavenging proteins. ROS-induced stimulation of protein 
phosphorylation pathways modulates transcription factor activities and gene expression, 
which results in a variety of responses such as cell necrosis or apoptosis. Here, 
H2O2-induced oxidative stress was found to be dependent on a significant production of 
ROS in EPCs which in turn was associated with an upregulation of Nox4, STAT-3, and 
eNOS. SAL significantly increased cell viability and declined cell death in EPCs subjected 
to H2O2-induced oxidative stress by reducing ROS formation and attenuating the increased 
expression of Nox4, STAT-3, and eNOS (Figure 19). NADPH oxidase is one of the most 
prominent sources of vascular ROS being expressed in a variety of vascular cells. The 
importance of NADPH oxidase in both vascular physiology and pathophysiology has been 
emphasized extensively (Frey et al., 2009; Li and Shah, 2003). Among other catalytic 
NADPH oxidase (Nox) homologues, Nox4 is abundantly expressed in ECs and functions as 
a key endothelial NADPH oxidase membrane component which is involved in the 
regulation of cell growth and cell survival in ECs (Ago et al., 2004). Nox4 is the major 
source of evoked O2
•−
 that triggers apoptosis in cerebral vascular ECs (Basuroy et al., 2009). 
Upregulation of Nox4 may have a direct influence on mitochondrial oxidative stress 
increase along with consequent mitochondrial dysfunction and cell death. In this regard, the 
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present data show that SAL and SalB attenuates the upregulation of NADPH oxidase and 
Nox4 expression (Figure 17, 19). The NADPH oxidase inhibitor DPI at least partially 
mediated the suppression of ROS and restored the cell survival rate by downregulating the 
cleaved caspase-3 and Bax/Bcl-xL protein expression (Figure 17). This suggests that the 
inhibition of ROS production and the subsequent protective effect of SAL and SalB against 
oxidation is likely to be related to the suppression of NADPH oxidase. Furthermore, cell 
apoptosis was suppressed by SAL and SalB after H2O2 provocation, which was evidenced 
by preventing the loss of MMP and maintaining the integrity of the plasma membrane 
(Figure 18).  
Members of the Bcl-2 family of proteins have a central role in controlling the apoptotic 
pathway. Some proteins within this family, including Bcl-2 and Bcl-xL, suppress apoptosis, 
while others such as Bax and Bak promote apoptosis. Hence, alterations in the levels of anti- 
and pro-apoptotic Bcl-2 family proteins are critical for the induction of apoptosis. We found 
that H2O2 stress resulted in an increased expression of Bax protein and a decreased 
expression of Bcl-xL. Pretreatment with SAL or ICAR reversed this effect thereby 
decreasing the Bax/Bcl-xL ratio (Figure 19). Therefore, it is conclusive to postulate that 
downregulation of Bax and upregulation of Bcl-xL may be responsible for the observed 
anti-apoptotic effect of them. Xu and co-workers found that SAL is capable of protecting 
HUVECs against H2O2-induced apoptosis by inhibiting ROS production and by activating 
the PI3-K/Akt/mTOR-dependent pathway (Xu et al., 2013). Dai et al. observed that the 
reduction of oxidative stress enhances ECs survival thereby facilitating ischemia-mediated 
angiogenesis (Dai et al., 2009). Taken together, it is likely that the antioxidative effect of 
SAL contributes to an increased angiogenic ability in BM-EPCs. 
On the one side, NO is beneficial as a messenger or modulator of angiogeneic events, 
however, on the other side it is potentially toxic under conditions of oxidative stress 
(Colasanti and Suzuki, 2000). The toxic effects of NO may be attributed to its free radical 
character, which makes NO react with superoxide (O2
-
) to produce a strong oxidant, 
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peroxynitrite (ONOO
-
), that may mediate much of the NO toxicity. In the present study, we 
showed that H2O2 induced the production of NO and that the expression of eNOS protein 
was restored by SalB to baseline level (Figure 17). Interestingly, NADPH oxidase inhibitor 
fully abrogated the increase in ROS generation as well as eNOS uncoupling triggered by 
H2O2, and abolished the effect of SalB, suggesting that NADPH functions upstream of 
eNOS underlying the action of SalB.  The oxidative-mediated autophagy was alleviated 
when eNOS was inhibited, indicating that elevated levels of ‘uncoupled eNOS’ derived 
from over-oxidation contributes to an increased generation of superoxide anions 
representing a critical step during the initiation of endothelial dysfunction.  
Prior studies have shown that the mTOR pathway plays a key role in the regulation of 
both resting oxygen consumption and oxidative capacity, and mTOR-raptor complex 
formation is tightly correlated with mitochondrial metabolism (Schieke et al., 2006). 
Oxidative stress can block the activity of mTOR signaling pathways to reverse cell 
metabolism and longevity leading to cell death (Andreucci et al., 2009; Chen et al., 2010). 
In contrast, activation of mTOR during oxidative stress can result in cytoprotection (Chen et 
al., 2010). We show that administration of both rapamycin and LY294002 during SalB 
application significantly prevented cellular protection by SalB illustrating that SalB relies 
upon the activation of mTOR to protect BM-EPCs against oxidative stress (Figure 20). 
Moreover, we provide evidence that loss of 4EBP1 significantly elevates cell apoptosis after 
H2O2 exposure, and abolishes the protection by SalB, suggesting that 4EBP1 controls 
caspase activation and modulates the proteins of the Bcl-2 family thereby mediating the 
ability of SalB to resist to oxidative injury. 
 Exogenous H2O2 mimics the effect of endogenous receptor-induced H2O2 and 
activates multiple kinases (Konishi et al., 1997; Sun et al., 2000). MAPK signaling 
pathways are well known to be affected by receptor ligand interactions, as well as by 
different stimuli placed on the cell (Sun et al., 2001). The well-characterized MAPK family 
members p38 MAPK, ERK1/2, and JNK play important roles in the coordination of cellular 
stress responses towards oxidation (Aggeli et al., 2006; Gutierrez-Uzquiza et al., 2012). 
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Each MAPK is activated by phosphorylation by specific upstream MAPK kinases (MKKs) 
as part of a three-tiered cascade of kinases (MAPK kinase kinase (MAPKKK)/MKK/MAPK) 
in response to a wide range of physiological and pathological stimuli. Mitochondrial 
dysfunction could result in cell death by release of mitochondrial proteins into the cytosol 
and subsequent activation of cell death execution molecules. Activation of MAPKs 
signaling pathways in response to a variety of stressors such as oxidative stress, also leads to 
apoptosis via the mitochondria-dependent pathway (Chen et al., 2013; Ghosh et al., 2011). 
To elucidate the mechanism underlying the cytoprotective effect of TCM extracts we 
investigated potentially relevant signaling pathways. Loss of MMP (Δψm), release of 
cytochrome c from mitochondria and subsequent activation of caspase-3 and cleavage of 
PARP are key steps in the mitochondrion-dependent apoptotic cell death pathway. 
Treatment with SalB and ICAR prior to H2O2 stress, however, counteracted 
mitochondrion-mediated apoptosis. It is known that SB203580 exerts its inhibitory effect by 
binding to the ATP binding pocket of p38 MAPK, thus inhibiting its ability to undergo 
autophosphorylation, but not affecting the capacity of p38 MAPK to be phosphorylated by 
upstream MAPKK, MKK3/6 (Figure 21). We found that H2O2-induced p38 phosphorylation 
was SB203580-sensitive, suggesting that the p38 MAPK autophosphorylation triggers cell 
apoptosis by differentially regulating the expression and/or activities of pro-and 
anti-apoptotic Bcl-2 family proteins. Moreover, we found that SalB-mediated attenuation of 
stress-stimulated p38 MAPK signaling includes the inhibition of phosphorylation of 
MKK3/6, its direct upstream activating kinases indicating that SalB regulates signaling 
events upstream of MAPKKs resulting in p38 MAPK activation. Unexpectedly, the 
phosphorylation of p38 MAPK was supported by inhibition of mTOR and by knockdown of 
4EBP1, resulting in subsequent enhanced cell injury (Figure 21). We hypothesize that 
oxidative stress induced activation of p38 MAPK suppresses the physiological 
mTOR/4EBP1 activity of proliferating and differentiating cells and, in turn, this loss of 
mTOR activity sensitizes the BM-EPCs to p38 mediated apoptosis. 
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ATF2 has been implicated in a large set of cellular stress responses, such as those 
exposed to proinflammatory cytokines, ultraviolet irradiation, DNA damage, change in ROS, 
and as a primary downstream target of p38 involved in the control of cell cycle progression 
(Bhoumik et al., 2007; Hayakawa et al., 2004; Lewis et al., 2005). In the present study, we 
have identified a novel role for ATF2 as an essential target of oxidative stress-dependent 
endothelial injury that mediate the stress-counteraction of SalB. ERK1/2 has been shown to 
have proliferative and protective effects on cells exposed to oxidative stress. Low and 
adequate concentrations of H2O2 is mitogenic, being partly due to activation of ERK1/2 
(Burdon, 1995). However recently, ERK1/2 was reported to exert a pro-apoptotic role 
depended on oxidative stress (Lee et al., 2006; Leong et al., 2011). The present findings 
suggest that blockade of H2O2-induced ERK1/2 by U0126 conveys survival signals as 
observed by enhanced cellular resistance towards oxidative stress accompanied by a 
decreased Bax/Bcl-xL ratio. Moreover, the possible downstream effector phosphorylated 
ATF2 was repressed by ERK1/2 inhibition (Figure 22).  
Autophagy occurs at basal level in most cells and contributes to the turnover of 
long-lived proteins and organelles to maintain intracellular homeostasis. In response to 
cellular stress, autophagy is upregulated and can provide an adaptive strategy for cell 
survival, but excessive autophagy causes cellular destruction and is referred to as type-II 
cell death.  Thus a full understanding of the signaling pathways that regulate autophagy 
will allow the development of new therapies to treat diseases in which this process is 
implicated. The microtubule-associated protein LC3 is an autophagosome ortholog of yeast 
Atg8, which is associated with autophagosome membranes after processing, and is modified 
via an ubiquitination-like system. The LC3 is now widely used to monitor autophagy that is 
a tipical early marker for the formation of autophagosomes. There are two cellular forms of 
the LC3 protein. One is LC3-I (18 kDa), a cytoplasmic form of LC3, and another one is 
LC3-II (16 kDa), a cleavage form of LC3, which is associated with the autophagosomal 
membrane.  Thus, the increased expression of LC3-II is associated with autophagy 
induction. In addition, the protein p62 SQSTM1 has been reported to interact with the 
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autophagic effector protein LC3 and is degraded through an autophagy-lysosome pathway. 
Beclin 1, the mammalian orthologue of yeast Atg6, can interacts with several cofactors 
(Atg14L, UVRAG, Bif-1, Rubicon, surviving, etc) to regulate the lipid kinase Vps-34 
protein and promote formation of Beclin 1-Vps34-Vps15 core complexes, thereby inducing 
autophagy (He and Levine, 2010). 
Worthy of note, investigators have demonstrated that oxidative stress could induce 
autophagy in vitro. Bhogal and colleagues reported that oxidative stress increases 
hepatocyte autophagy in a ROS-dependent manner, and mitochondrial ROS and NADPH 
are found to be key regulators of autophagy (Bhogal et al., 2012). Consistent with prior 
reports, our results show that pathophysiological concentrations of H2O2 induces 
autophagosome formation in cultured human BM-EPCs. However, co-treatment of ICAR 
reduced H2O2-induced autophagy as indicated by multiple independent approaches that 
either revealed the formation of autophagic vacuoles or the expression of autophagy specific 
proteins (Figure 23). 
Numerous autophagic pathways converge at the mTOR, which when phosphorylated 
becomes a potent inhibitor of autophagy. Silencing of mTOR using siRNA transfection was 
known to enhance rapamycin-induced autophagy (Ravikumar et al., 2004). Interestingly, we 
found that p-mTOR expression was reduced but LC3-II expression was elevated by 
oxidative stress; however, such effect was notably attenuated by ICAR. To further test the 
involvement of mTOR-dependent pathway in this protective process, we applied rapamycin, 
a specific inhibitor of mTOR, to the cells before administration of H2O2 or ICAR. We found 
that p-mTOR was significantly inhibited by H2O2 in the presence of rapamycin, and 
ICAR-induced suppression of LC3-II expression was partially blocked by pretreated with 
rapamycin. Moreover, ICAR-induced suppression of autophagy was partially blocked by 
pretreated with rapamycin. In our system, the autophagy inhibitor 3-MA suppressed the 
oxidative stress induced-cell death, further strengthening the association between autophagy, 
ROS, and cell death (Figure 23). 
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There are many reports on the effect of p38 MAPK in autophagy. However, depending 
on the stimulus and the cell type, p38MAPK has been described to act either as a positive or 
as a negative regulator of this process. For example, it has been described that LPS 
(lipopolysaccharide) and interferon-γ activate p38 MAPK inducing autophagy (Doyle et al., 
2011; Matsuzawa et al., 2012). In contrast, Webber and co-workers showed that in full 
medium p38 MAPK is phosphorylated and inhibits autophagy by sequestering p38-IP 
(p38-interacting protein) (Webber and Tooze, 2010). In the present study, we have observed 
that p38 MAPK phosphorylation is induced under oxidative conditions and that inhibition of 
p38 MAPK by SB203580 prevents the accumulation of LC3-II, suggesting that p38 MAPK 
is necessary for the activation of autophagy by H2O2 (Figure 24). The substrates of p38 
MAPK, ATF2 was also phosphorylated after the addition of H2O2. When ATF2 was 
knocked down, a reduced level of cell death was correlated with the observed decreased 
amount of ROS accumulation, and the H2O2-induced autophagy. Since p38 MAPK also 
translocates to the nucleus after H2O2 treatment, it is tempting to hypothesize that this 
activates some transcription factors, e.g. ATF2, that will drive the expression of genes 
implicated in autophagy induction. Furthermore, when examined the phosphorylation status 
of p38 MAPK and mTOR after H2O2 and rapamycin treatment, we found that induction of 
autophagy by rapamycin significantly increased oxidative stress-induced apoptosis which 
was all largely reversed by SB203580 (Figure 26). Thus, we concluded that H2O2 induced 
autophagy via activation of p38 MAPK, which functions through the downstream inhibition 
of the mTOR signaling pathway.  
Here, we also present evidence supporting that the ROS-dependent ERK activation by 
oxidation plays an important role in autophagy induction. ERK activation appears to have 
divergent roles in autophagy in different cell types. ERK upregulates starvation-induced 
autophagy by down-regulating Akt/mTOR/S6K (Shinojima et al., 2007). Wang and 
co-workers proposed that a non-canonical MEK/ERK module regulates autophagy by 
modulating Beclin 1 level through an AMPK-MEK/ERK-TSC-mTOR signaling pathway 
(Wang et al., 2009). In our study pathophysiological levels of H2O2 induces an autophagic 
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phenotype that is also mediated by ERK activation in addition to mTOR signaling pathway 
(Figure 25). These findings suggest that the regulation of autophagy by ROS involves 
multiple kinase signaling pathways, and underlining a possible universal mechanism in 
autophagy regulation through mTOR.  
The mechanisms of apoptosis and autophagy are different, and involve fundamentally 
distinct sets of regulatory and executioner molecules. Although autophagy is independent of 
apoptosis, it could act in conjunction with apoptosis to induce neurotoxic cell death 
(Nopparat et al., 2010). In our study, both autophagy and apoptosis are involved in 
protection of ICAR against H2O2-induced injury in BM-EPCs. We hypothesized that 
MAPK/P38 MAPK signaling, which is induced by ROS accumulation, downregulates 
mTOR function and subsequently activates the apoptosis and autophagy pathway. 
Taken together, the present study demonstrated that SAL, ICAR and PUER promote 
cell growth, cell migration, cell-matrix and capillary-like tube formation of BM-EPCs. The 
results provide mechanistic evidence that activation of the mTOR/p70S6K/4EBP1 pathways 
is required for both SAL and ICAR-mediated pro-proliferative and pro-angionenic effects in 
BM-EPCs. In addition, SAL, SalB and ICAR attenuate the cytotoxic and pro-apoptotic 
effect of H2O2 in vitro. Suppression of MKK3/6-p38 MAPK-ATF2 and ERK1/2 signaling 
pathways, and maintenance of mTOR/4EBP1 activity are associated with the reduction of 
oxidative stress-induced intracellular ROS levels and apoptosis mediated by SalB and ICAR. 
The investigation also found that ICAR owns the ability to inhibit apoptotic and autophagic 
programmed cell death via restoring the loss of mTOR and attenuation of ATF2 activity 
upon oxidative stress. Based on the outcomes of the present work, we propose SAL, SalB 
and ICAR as novel proanigiogenic and cytoprotective therapeutic agents with potential 
applications in the fields of systemic and site-specific tissue regeneration including 
ischaemic disease and extended musculoskeletal tissue defects. 
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                                                            Summary of the thesis                                      
 
1. Human endothelial progenitor cells were successfully isolated and induced from bone 
marrow-derived mononuclear cells, which exhibiting prominent proliferative and 
capillary-like tube formation capacities, as well as the ability to differentiate towards 
mature endothelial cells. 
 
2. SAL, SalB, ICAR and PUER show promoting effects on cell angiogenic abilities, 
including cell chemotaxis, cell-matrix adhesion, and capillary-like tube formation in 
vitro. 
 
3. SAL and ICAR suppress cell-cell adhesion of BM-EPCs, elevate the secretion level of 
VEGF and NO, and regulate endothelial marker gene expression.  
 
4. Akt/mTOR/p70S6K/4EBP1 and ERK1/2 signaling pathways are involved in the 
angiogenic effects of SAL and ICAR. 
 
5. SAL, SalB and ICAR substantially abrogate H2O2-induced cell injury on BM-EPCs, 
contributing to their increased angiogenic ability. 
 
6. SAL, SalB and ICAR suppress H2O2-provoked generation of ROS and expression of 
NADPH, and downregulate gene expression levels of Nox4 and eNOS. Furthermore, 
NADPH functions upstream of eNOS underlying the action of SalB.  
 
 
7. Constitutive activation of MKK3/6 contributes to the baseline level of p38 MAPK 
activation that is independent of H2O2-triggered p38 MAPK phosphorylation in 
BM-EPCs. 
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8. SAL, SalB and ICAR protect mitochondrial function and inhibit 
mitochondrion-mediated apoptosis by decreasing cytochrome c release, inhibiting the 
cleavage of PARP, inactivating of caspase 3, and downregulating Bax/Bcl-xL ratio. 
 
9. Maintenance of mTOR kinase and its downstream target 4EBP1 are responsible for the 
protective potential of ICAR on oxidation stressed-BM-EPCs. The loss of mTOR 
/4EBP1activity sensitizes BM-EPCs to p38 MAPK mediated apoptosis. 
 
10.  4EBP1 controls caspase activation and modulates the proteins of Bcl-2 family thereby 
mediating the ability of SalB to block cell-injury activity caused by oxidative stress. 
 
11.  Elevated levels of ‘uncoupled eNOS’ derived from over-oxidation contributes to an    
increased degree of apoptotic and autophagic programmed cell death. 
 
12.  ICAR restores loss of mTOR/4EBP1 activity upon oxidative stress, which is associated 
with cell autophagy inhibition. 
 
13.  mTOR inhibition is associated with increased ERK1/2 activity in response to oxidative 
stress that mediats H2O2-induced autophagy. 
 
14.  p38 MAPK/ATF2 acts as a negative upstream signal pathway regulating 
mTOR-mediated apoptosis and autophagy during ROS accumulation. And p38 MAPK 
activation lies eNOS activity to induce apoptotic and autophagic cell death. 
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